Financial Metrics
VRTX VERTEX PHARMACEUTICALS INC / MAFinancial Statements
Grouped by statementIncome Statement
Metrics: 6Revenue
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 398080000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 431608000.0 | +8.4% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 413783000.0 | -4.1% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 714718000.0 | +72.7% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 544135000.0 | -23.9% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 578165000.0 | +6.3% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 640799000.0 | +10.8% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 752157000.0 | +17.4% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 784535000.0 | +4.3% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 858435000.0 | +9.4% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 941293000.0 | +9.7% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 949828000.0 | +0.9% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 1515107000.0 | +59.5% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 1524485000.0 | +0.6% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 1538271000.0 | +0.9% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 1724300000.0 | +12.1% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 1793400000.0 | +4.0% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 1984100000.0 | +10.6% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 2097500000.0 | +5.7% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 2196200000.0 | +4.7% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 2334300000.0 | +6.3% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 2374800000.0 | +1.7% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 2493200000.0 | +5.0% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 2483500000.0 | -0.4% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 2690600000.0 | +8.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 2645600000.0 | -1.7% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 2771900000.0 | +4.8% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 2770200000.0 | -0.1% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 2964700000.0 | +7.0% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 3076400000.0 | +3.8% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 1702177000.0 | — | USD | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 2488652000.0 | +46.2% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 3047597000.0 | +22.5% | USD | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 4162800000.0 | +36.6% | USD | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 6205700000.0 | +49.1% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 7574400000.0 | +22.1% | USD | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 8930700000.0 | +17.9% | USD | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 9869200000.0 | +10.5% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 11020100000.0 | +11.7% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 12001300000.0 | +8.9% | USD | 10-K | 2026-02-13 |
Gross Profit
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Operating Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -14330000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 3353000.0 | +123.4% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -18727000.0 | -658.5% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 270842000.0 | +1546.3% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 52707000.0 | -80.5% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -326043000.0 | -718.6% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 128901000.0 | +139.5% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 172878000.0 | +34.1% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 205649000.0 | +19.0% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 276808000.0 | +34.6% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 269960000.0 | -2.5% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 99333000.0 | -63.2% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 720224000.0 | +625.1% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 718033000.0 | -0.3% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 672241000.0 | -6.4% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 887800000.0 | +32.1% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -37900000.0 | -104.3% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 1054500000.0 | +2882.3% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 1040900000.0 | -1.3% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 1106300000.0 | +6.3% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 1126700000.0 | +1.8% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 779000000.0 | -30.9% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 1026400000.0 | +31.8% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 1038100000.0 | +1.1% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 1139500000.0 | +9.8% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -3514700000.0 | -408.4% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 1116300000.0 | +131.8% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 630100000.0 | -43.6% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1151100000.0 | +82.7% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 1186200000.0 | +3.0% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 9936000.0 | — | USD | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 123243000.0 | +1140.4% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 635150000.0 | +415.4% | USD | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 1197500000.0 | +88.5% | USD | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 2856300000.0 | +138.5% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 2782100000.0 | -2.6% | USD | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 4307400000.0 | +54.8% | USD | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 3832000000.0 | -11.0% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -232900000.0 | -106.1% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 4173300000.0 | +1891.9% | USD | 10-K | 2026-02-13 |
Net Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -36102000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | -36151000.0 | -0.1% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -39537000.0 | -9.4% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 249548000.0 | +731.2% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 31169000.0 | -87.5% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -291267000.0 | -1034.5% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 227301000.0 | +178.0% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 206250000.0 | -9.3% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 128456000.0 | -37.7% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 268631000.0 | +109.1% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 267427000.0 | -0.4% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 57518000.0 | -78.5% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 602753000.0 | +947.9% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 837270000.0 | +38.9% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 667434000.0 | -20.3% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 653100000.0 | -2.1% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 67000000.0 | -89.7% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 851900000.0 | +1171.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 762100000.0 | -10.5% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 810500000.0 | +6.4% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 930500000.0 | +14.8% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 699800000.0 | -24.8% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 915700000.0 | +30.9% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 1035300000.0 | +13.1% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 1099600000.0 | +6.2% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -3593600000.0 | -426.8% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 1045400000.0 | +129.1% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 646300000.0 | -38.2% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1032900000.0 | +59.8% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 1082900000.0 | +4.8% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | -84031000.0 | — | USD | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 91635000.0 | +209.0% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 2087103000.0 | +2177.6% | USD | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 1176800000.0 | -43.6% | USD | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 2711700000.0 | +130.4% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 2342100000.0 | -13.6% | USD | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 3322000000.0 | +41.8% | USD | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 3619600000.0 | +9.0% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -535600000.0 | -114.8% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 3953200000.0 | +838.1% | USD | 10-K | 2026-02-13 |
EPS Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.17 | — | USD/shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | -0.26 | -52.9% | USD/shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -0.16 | +38.5% | USD/shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 1.01 | +731.2% | USD/shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.07 | -93.1% | USD/shares | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -0.41 | -685.7% | USD/shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.83 | +302.4% | USD/shares | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 0.82 | -1.2% | USD/shares | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 0.51 | -37.8% | USD/shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 1.05 | +105.9% | USD/shares | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 1.04 | -1.0% | USD/shares | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 0.22 | -78.8% | USD/shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 2.32 | +954.5% | USD/shares | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 3.22 | +38.8% | USD/shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 2.56 | -20.5% | USD/shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 2.52 | -1.6% | USD/shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 0.26 | -89.7% | USD/shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 3.3 | +1169.2% | USD/shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 2.99 | -9.4% | USD/shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 3.17 | +6.0% | USD/shares | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 3.63 | +14.5% | USD/shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 2.72 | -25.1% | USD/shares | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 3.55 | +30.5% | USD/shares | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 4.01 | +13.0% | USD/shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 4.26 | +6.2% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -13.92 | -426.8% | USD/shares | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 4.05 | +129.1% | USD/shares | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 2.52 | -37.8% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 4.02 | +59.5% | USD/shares | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 4.24 | +5.5% | USD/shares | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | -0.46 | — | USD/shares | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 1.06 | +330.4% | USD/shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 8.24 | +677.4% | USD/shares | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 4.58 | -44.4% | USD/shares | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 10.44 | +127.9% | USD/shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 9.09 | -12.9% | USD/shares | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 12.97 | +42.7% | USD/shares | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 14.05 | +8.3% | USD/shares | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -2.08 | -114.8% | USD/shares | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 15.46 | +843.3% | USD/shares | 10-K | 2026-02-13 |
EPS Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.17 | — | USD/shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | -0.26 | -52.9% | USD/shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -0.16 | +38.5% | USD/shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 0.99 | +718.7% | USD/shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.07 | -92.9% | USD/shares | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -0.41 | -685.7% | USD/shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.81 | +297.6% | USD/shares | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 0.8 | -1.2% | USD/shares | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 0.5 | -37.5% | USD/shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 1.03 | +106.0% | USD/shares | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 1.03 | +0.0% | USD/shares | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 0.22 | -78.6% | USD/shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 2.29 | +940.9% | USD/shares | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 3.18 | +38.9% | USD/shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 2.53 | -20.4% | USD/shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 2.49 | -1.6% | USD/shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 0.26 | -89.6% | USD/shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 3.28 | +1161.5% | USD/shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 2.96 | -9.8% | USD/shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 3.13 | +5.7% | USD/shares | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 3.59 | +14.7% | USD/shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 2.69 | -25.1% | USD/shares | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 3.52 | +30.9% | USD/shares | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 3.97 | +12.8% | USD/shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 4.21 | +6.0% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -13.92 | -430.6% | USD/shares | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 4.01 | +128.8% | USD/shares | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 2.49 | -37.9% | USD/shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 3.99 | +60.2% | USD/shares | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 4.2 | +5.3% | USD/shares | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | -0.46 | — | USD/shares | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 1.04 | +326.1% | USD/shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 8.09 | +677.9% | USD/shares | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 4.51 | -44.3% | USD/shares | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 10.29 | +128.2% | USD/shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 9.01 | -12.4% | USD/shares | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 12.82 | +42.3% | USD/shares | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 13.89 | +8.3% | USD/shares | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -2.08 | -115.0% | USD/shares | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 15.32 | +836.5% | USD/shares | 10-K | 2026-02-13 |
Balance Sheet
Metrics: 9Cash and Equivalents
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 604245000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 605866000.0 | +0.3% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 719692000.0 | +18.8% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2016-12-31 | 1183945000.0 | +64.5% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2017-03-31 | 1003679000.0 | -15.2% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 1223130000.0 | +21.9% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 1384966000.0 | +13.2% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2017-12-31 | 1665412000.0 | +20.2% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2018-03-31 | 1995893000.0 | +19.8% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 2145359000.0 | +7.5% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 2478302000.0 | +15.5% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2018-12-31 | 2650134000.0 | +6.9% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2019-03-31 | 2893885000.0 | +9.2% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 3294684000.0 | +13.8% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 3397941000.0 | +3.1% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2019-12-31 | 3109322000.0 | -8.5% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2020-03-31 | 3593412000.0 | +15.6% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 4831332000.0 | +34.4% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 5358087000.0 | +10.9% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2020-12-31 | 5988200000.0 | +11.8% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-03-31 | 6304300000.0 | +5.3% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 6063700000.0 | -3.8% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 6275700000.0 | +3.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-12-31 | 6795000000.0 | +8.3% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2022-03-31 | 7600100000.0 | +11.8% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 8702200000.0 | +14.5% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 9171500000.0 | +5.4% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2022-12-31 | 10504000000.0 | +14.5% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2023-03-31 | 9289900000.0 | -11.6% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 10151100000.0 | +9.3% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 11110200000.0 | +9.4% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2023-12-31 | 10369100000.0 | -6.7% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2024-03-31 | 9158000000.0 | -11.7% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 4580100000.0 | -50.0% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 5239200000.0 | +14.4% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2024-12-31 | 4569600000.0 | -12.8% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 4674700000.0 | +2.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 4972200000.0 | +6.4% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 4939600000.0 | -0.7% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 1183945000.0 | — | USD | 10-K | 2020-02-13 |
| Annual | 2017-12-31 | 1665412000.0 | +40.7% | USD | 10-K | 2021-02-11 |
| Annual | 2018-12-31 | 2650100000.0 | +59.1% | USD | 10-K | 2022-02-09 |
| Annual | 2019-12-31 | 3109300000.0 | +17.3% | USD | 10-K | 2023-02-10 |
| Annual | 2020-12-31 | 5988200000.0 | +92.6% | USD | 10-K | 2024-02-15 |
| Annual | 2021-12-31 | 6795000000.0 | +13.5% | USD | 10-K | 2025-02-13 |
| Annual | 2022-12-31 | 10504000000.0 | +54.6% | USD | 10-K | 2026-02-13 |
| Annual | 2023-12-31 | 10369100000.0 | -1.3% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 4569600000.0 | -55.9% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 5084800000.0 | +11.3% | USD | 10-K | 2026-02-13 |
Accounts Receivable
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 181878000.0 | — | USD | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 189356000.0 | +4.1% | USD | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 182229000.0 | -3.8% | USD | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 201083000.0 | +10.3% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 207955000.0 | +3.4% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 247949000.0 | +19.2% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 263493000.0 | +6.3% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 281343000.0 | +6.8% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-01-01 | 311224000.0 | +10.6% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 327294000.0 | +5.2% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 393439000.0 | +20.2% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 379755000.0 | -3.5% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 409688000.0 | +7.9% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 438297000.0 | +7.0% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 464900000.0 | +6.1% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 443315000.0 | -4.6% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 633518000.0 | +42.9% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 845269000.0 | +33.4% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 791768000.0 | -6.3% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 791917000.0 | +0.0% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 885352000.0 | +11.8% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 977551000.0 | +10.4% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 929142000.0 | -5.0% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 1100372000.0 | +18.4% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 1136800000.0 | +3.3% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 1292800000.0 | +13.7% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 1332900000.0 | +3.1% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 1385200000.0 | +3.9% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 1442200000.0 | +4.1% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 1547800000.0 | +7.3% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 1556200000.0 | +0.5% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 1538700000.0 | -1.1% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 1563400000.0 | +1.6% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 1793200000.0 | +14.7% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 1656100000.0 | -7.6% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 1750600000.0 | +5.7% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 1609400000.0 | -8.1% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 1805100000.0 | +12.2% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1893500000.0 | +4.9% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 1946400000.0 | +2.8% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 200364000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 281343000.0 | +40.4% | USD | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 409688000.0 | +45.6% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 633518000.0 | +54.6% | USD | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 885400000.0 | +39.8% | USD | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 1136800000.0 | +28.4% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 1442200000.0 | +26.9% | USD | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 1563400000.0 | +8.4% | USD | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 1609400000.0 | +2.9% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 2052800000.0 | +27.6% | USD | 10-K | 2026-02-13 |
Inventory
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 63200000.0 | — | USD | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 66589000.0 | +5.4% | USD | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 71799000.0 | +7.8% | USD | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 77604000.0 | +8.1% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 82020000.0 | +5.7% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 92263000.0 | +12.5% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 98192000.0 | +6.4% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 111830000.0 | +13.9% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-01-01 | 111740000.0 | -0.1% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 117346000.0 | +5.0% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 115025000.0 | -2.0% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 124150000.0 | +7.9% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 124360000.0 | +0.2% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 136698000.0 | +9.9% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 143017000.0 | +4.6% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 162306000.0 | +13.5% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 167502000.0 | +3.2% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 187087000.0 | +11.7% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 219218000.0 | +17.2% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 245460000.0 | +12.0% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 280777000.0 | +14.4% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 298863000.0 | +6.4% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 321620000.0 | +7.6% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 333456000.0 | +3.7% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 353100000.0 | +5.9% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 338900000.0 | -4.0% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 367700000.0 | +8.5% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 388200000.0 | +5.6% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 460600000.0 | +18.7% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 535100000.0 | +16.2% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 603500000.0 | +12.8% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 688700000.0 | +14.1% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 738800000.0 | +7.3% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 813100000.0 | +10.1% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 914600000.0 | +12.5% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 1079800000.0 | +18.1% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 1205400000.0 | +11.6% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 1359700000.0 | +12.8% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1499300000.0 | +10.3% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 1626800000.0 | +8.5% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 77604000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 111830000.0 | +44.1% | USD | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 124360000.0 | +11.2% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 167502000.0 | +34.7% | USD | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 280800000.0 | +67.6% | USD | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 353100000.0 | +25.7% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 460600000.0 | +30.4% | USD | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 738800000.0 | +60.4% | USD | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 1205400000.0 | +63.2% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 1686800000.0 | +39.9% | USD | 10-K | 2026-02-13 |
Current Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1402835000.0 | — | USD | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 1454150000.0 | +3.7% | USD | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 1501901000.0 | +3.3% | USD | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 1831540000.0 | +21.9% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 1871814000.0 | +2.2% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 2180572000.0 | +16.5% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 2327974000.0 | +6.8% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 2648963000.0 | +13.8% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 3041116000.0 | +14.8% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 3407423000.0 | +12.0% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 3686611000.0 | +8.2% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 3843109000.0 | +4.2% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 4183039000.0 | +8.8% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 4710968000.0 | +12.6% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 4777094000.0 | +1.4% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 4822829000.0 | +1.0% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 5446400000.0 | +12.9% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 6694320000.0 | +22.9% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 7458456000.0 | +11.4% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 8133379000.0 | +9.0% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 8539307000.0 | +5.0% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 8457514000.0 | -1.0% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 8852540000.0 | +4.7% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 9560600000.0 | +8.0% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 10361300000.0 | +8.4% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 11503500000.0 | +11.0% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 12271000000.0 | +6.7% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 13234800000.0 | +7.9% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 12965700000.0 | -2.0% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 13872900000.0 | +7.0% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 14695800000.0 | +5.9% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 14144200000.0 | -3.8% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 13288700000.0 | -6.0% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 8941600000.0 | -32.7% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 9804100000.0 | +9.6% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 9596400000.0 | -2.1% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 10008800000.0 | +4.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 10427900000.0 | +4.2% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 10569600000.0 | +1.4% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 1831540000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 2648963000.0 | +44.6% | USD | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 3843109000.0 | +45.1% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 4822829000.0 | +25.5% | USD | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 8133400000.0 | +68.6% | USD | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 9560600000.0 | +17.5% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 13234800000.0 | +38.4% | USD | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 14144200000.0 | +6.9% | USD | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 9596400000.0 | -32.2% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 11201000000.0 | +16.7% | USD | 10-K | 2026-02-13 |
Total Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 2487906000.0 | — | USD | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 2548982000.0 | +2.5% | USD | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 2609641000.0 | +2.4% | USD | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 2896787000.0 | +11.0% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 2946703000.0 | +1.7% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 3285594000.0 | +11.5% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 3198325000.0 | -2.7% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 3546014000.0 | +10.9% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-01-01 | 3558639000.0 | +0.4% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 3952974000.0 | +11.1% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 4335386000.0 | +9.7% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 4620840000.0 | +6.6% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 6245898000.0 | +35.2% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-01-01 | 6261958000.0 | +0.3% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 6543114000.0 | +4.5% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 7033471000.0 | +7.5% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 7514553000.0 | +6.8% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 8318465000.0 | +10.7% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 8893201000.0 | +6.9% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 10216367000.0 | +14.9% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 11301633000.0 | +10.6% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 11751808000.0 | +4.0% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 12115059000.0 | +3.1% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 12221686000.0 | +0.9% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 12618745000.0 | +3.2% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 13432500000.0 | +6.4% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 14256100000.0 | +6.1% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 15582200000.0 | +9.3% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 16706400000.0 | +7.2% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 18150900000.0 | +8.6% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 18974200000.0 | +4.5% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 20349200000.0 | +7.2% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 21726200000.0 | +6.8% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 22730200000.0 | +4.6% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 23917400000.0 | +5.2% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 20132100000.0 | -15.8% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 22240200000.0 | +10.5% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 22533200000.0 | +1.3% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 22880500000.0 | +1.5% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 24036700000.0 | +5.1% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 24862300000.0 | +3.4% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 2896787000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 3546014000.0 | +22.4% | USD | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 6245898000.0 | +76.1% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 8318465000.0 | +33.2% | USD | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 11751800000.0 | +41.3% | USD | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 13432500000.0 | +14.3% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 18150900000.0 | +35.1% | USD | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 22730200000.0 | +25.2% | USD | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 22533200000.0 | -0.9% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 25643000000.0 | +13.8% | USD | 10-K | 2026-02-13 |
Current Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 552041000.0 | — | USD | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 622855000.0 | +12.8% | USD | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 722841000.0 | +16.1% | USD | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 792537000.0 | +9.6% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 489796000.0 | -38.2% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 625406000.0 | +27.7% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 710739000.0 | +13.6% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 807260000.0 | +13.6% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 827312000.0 | +2.5% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 927300000.0 | +12.1% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 992508000.0 | +7.0% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 1120292000.0 | +12.9% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 1106468000.0 | -1.2% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 1259220000.0 | +13.8% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 1388894000.0 | +10.3% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 1334827000.0 | -3.9% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 1538750000.0 | +15.3% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 1798640000.0 | +16.9% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 2004026000.0 | +11.4% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 1877533000.0 | -6.3% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 1944050000.0 | +3.5% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 1836448000.0 | -5.5% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 1914264000.0 | +4.2% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 2142000000.0 | +11.9% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 2180200000.0 | +1.8% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 2556200000.0 | +17.2% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 2609300000.0 | +2.1% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 2742100000.0 | +5.1% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 3026200000.0 | +10.4% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 3352100000.0 | +10.8% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 3599400000.0 | +7.4% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 3547400000.0 | -1.4% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 3795900000.0 | +7.0% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 3547200000.0 | -6.6% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 3973100000.0 | +12.0% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 3564600000.0 | -10.3% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 3783200000.0 | +6.1% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 4138400000.0 | +9.4% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 4475300000.0 | +8.1% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 792537000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 807260000.0 | +1.9% | USD | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 1120292000.0 | +38.8% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 1334827000.0 | +19.1% | USD | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 1877500000.0 | +40.7% | USD | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 2142000000.0 | +14.1% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 2742100000.0 | +28.0% | USD | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 3547400000.0 | +29.4% | USD | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 3564600000.0 | +0.5% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 3861200000.0 | +8.3% | USD | 10-K | 2026-02-13 |
Total Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1371708000.0 | — | USD | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 1380137000.0 | +0.6% | USD | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 1401300000.0 | +1.5% | USD | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 1558596000.0 | +11.2% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 1263910000.0 | -18.9% | USD | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 1418363000.0 | +12.2% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 1395081000.0 | -1.6% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 1503708000.0 | +7.8% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 1522153000.0 | +1.2% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 1620503000.0 | +6.5% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 1686359000.0 | +4.1% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 1810695000.0 | +7.4% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 1819801000.0 | +0.5% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 1963506000.0 | +7.9% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 2261159000.0 | +15.2% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 2233221000.0 | -1.2% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 2431547000.0 | +8.9% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 2697125000.0 | +10.9% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 3168160000.0 | +17.5% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 3064993000.0 | -3.3% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 3134805000.0 | +2.3% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 3025290000.0 | -3.5% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 3088037000.0 | +2.1% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 3332500000.0 | +7.9% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 3349100000.0 | +0.5% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 3648700000.0 | +8.9% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 3676800000.0 | +0.8% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 4238200000.0 | +15.3% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 4541900000.0 | +7.2% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 4879000000.0 | +7.4% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 5213400000.0 | +6.9% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 5149800000.0 | -1.2% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 5370800000.0 | +4.3% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 5357400000.0 | -0.2% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 6609300000.0 | +23.4% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 6123600000.0 | -7.3% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 6384200000.0 | +4.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 6861300000.0 | +7.5% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 7543500000.0 | +9.9% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 1558596000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 1503708000.0 | -3.5% | USD | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 1810695000.0 | +20.4% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 2233221000.0 | +23.3% | USD | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 3065000000.0 | +37.2% | USD | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 3332500000.0 | +8.7% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 4238200000.0 | +27.2% | USD | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 5149800000.0 | +21.5% | USD | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 6123600000.0 | +18.9% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 6977200000.0 | +13.9% | USD | 10-K | 2026-02-13 |
Stockholders' Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1116198000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 1168845000.0 | +4.7% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 1208341000.0 | +3.4% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2016-12-31 | 1338191000.0 | +10.7% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2017-03-31 | 1682793000.0 | +25.8% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 1867231000.0 | +11.0% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 1803244000.0 | -3.4% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2017-12-31 | 2042306000.0 | +13.3% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2018-03-31 | 2430821000.0 | +19.0% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-06-30 | 2714883000.0 | +11.7% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2018-09-30 | 2934481000.0 | +8.1% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2018-12-31 | 4435203000.0 | +51.1% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2019-03-31 | 4723313000.0 | +6.5% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-06-30 | 5069965000.0 | +7.3% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2019-09-30 | 5253394000.0 | +3.6% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2019-12-31 | 6085244000.0 | +15.8% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2020-03-31 | 6461654000.0 | +6.2% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-06-30 | 7519242000.0 | +16.4% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2020-09-30 | 8133473000.0 | +8.2% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2020-12-31 | 8686800000.0 | +6.8% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-03-31 | 8980300000.0 | +3.4% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-06-30 | 9196400000.0 | +2.4% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-09-30 | 9530800000.0 | +3.6% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2021-12-31 | 10100000000.0 | +6.0% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2022-03-31 | 10907000000.0 | +8.0% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-06-30 | 11933500000.0 | +9.4% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2022-09-30 | 13029600000.0 | +9.2% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2022-12-31 | 13912700000.0 | +6.8% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2023-03-31 | 14432300000.0 | +3.7% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-06-30 | 15470200000.0 | +7.2% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2023-09-30 | 16512800000.0 | +6.7% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2023-12-31 | 17580400000.0 | +6.5% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2024-03-31 | 18546600000.0 | +5.5% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-06-30 | 14774700000.0 | -20.3% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2024-09-30 | 15630900000.0 | +5.8% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2024-12-31 | 16409600000.0 | +5.0% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 16496300000.0 | +0.5% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-06-30 | 17175400000.0 | +4.1% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-09-30 | 17318800000.0 | +0.8% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 1338191000.0 | — | USD | 10-K | 2020-02-13 |
| Annual | 2017-12-31 | 2042306000.0 | +52.6% | USD | 10-K | 2021-02-11 |
| Annual | 2018-12-31 | 4435200000.0 | +117.2% | USD | 10-K | 2022-02-09 |
| Annual | 2019-12-31 | 6085200000.0 | +37.2% | USD | 10-K | 2023-02-10 |
| Annual | 2020-12-31 | 8686800000.0 | +42.8% | USD | 10-K | 2024-02-15 |
| Annual | 2021-12-31 | 10100000000.0 | +16.3% | USD | 10-K | 2025-02-13 |
| Annual | 2022-12-31 | 13912700000.0 | +37.7% | USD | 10-K | 2026-02-13 |
| Annual | 2023-12-31 | 17580400000.0 | +26.4% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 16409600000.0 | -6.7% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 18665800000.0 | +13.7% | USD | 10-K | 2026-02-13 |
Long-Term Debt
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Cash Flow
Metrics: 4Operating Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -15137000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 25723000.0 | +269.9% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 91379000.0 | +255.2% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 265692000.0 | +190.8% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 447345000.0 | +68.4% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 617431000.0 | +38.0% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 252657000.0 | -59.1% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 574360000.0 | +127.3% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 955708000.0 | +66.4% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 324784000.0 | -66.0% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 788533000.0 | +142.8% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 1123322000.0 | +42.5% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 815698000.0 | -27.4% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 1854225000.0 | +127.3% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 2761973000.0 | +49.0% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 921000000.0 | -66.7% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 721300000.0 | -21.7% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 1648500000.0 | +128.5% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 956200000.0 | -42.0% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 2096000000.0 | +119.2% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 3051500000.0 | +45.6% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 899900000.0 | -70.5% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 2034300000.0 | +126.1% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 3302700000.0 | +62.4% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 1306600000.0 | -60.4% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -2447000000.0 | -287.3% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | -1077200000.0 | +56.0% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 818900000.0 | +176.0% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1892000000.0 | +131.0% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 3133400000.0 | +65.6% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 236103000.0 | — | USD | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 844942000.0 | +257.9% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 1270286000.0 | +50.3% | USD | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 1569300000.0 | +23.5% | USD | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 3253500000.0 | +107.3% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 2643500000.0 | -18.7% | USD | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 4129900000.0 | +56.2% | USD | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 3537300000.0 | -14.3% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -492600000.0 | -113.9% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 3631400000.0 | +837.2% | USD | 10-K | 2026-02-13 |
Investing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -102708000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | -160490000.0 | -56.3% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -125699000.0 | +21.7% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | -160979000.0 | -28.1% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | -237262000.0 | -47.4% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -462543000.0 | -95.0% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 4933000.0 | +101.1% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | -111365000.0 | -2357.6% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | -161254000.0 | -44.8% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | -39138000.0 | +75.7% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | -89328000.0 | -128.2% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | -338327000.0 | -278.7% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 31666000.0 | +109.4% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 103578000.0 | +227.1% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | -144359000.0 | -239.4% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | -74300000.0 | +48.5% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -154000000.0 | -107.3% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -206900000.0 | -34.4% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | -51000000.0 | +75.4% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | -112500000.0 | -120.6% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | -496700000.0 | -341.5% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | -1833600000.0 | -269.2% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | -2137500000.0 | -16.6% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | -2255200000.0 | -5.5% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | -2136400000.0 | +5.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -2600100000.0 | -21.7% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | -2948100000.0 | -13.4% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | -55800000.0 | +98.1% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | -540300000.0 | -868.3% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | -657300000.0 | -21.7% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 51238000.0 | — | USD | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | -483329000.0 | -1043.3% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | -202158000.0 | +58.2% | USD | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | -1235300000.0 | -511.1% | USD | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 99400000.0 | +108.0% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | -340900000.0 | -443.0% | USD | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | -321100000.0 | +5.8% | USD | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | -3141700000.0 | -878.4% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -3770000000.0 | -20.0% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | -945400000.0 | +74.9% | USD | 10-K | 2026-02-13 |
Financing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 4702000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 25955000.0 | +452.0% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 39509000.0 | +52.2% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | -289565000.0 | -832.9% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | -157532000.0 | +45.6% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -4827000.0 | +96.9% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 78956000.0 | +1735.7% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 27748000.0 | -64.9% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 29827000.0 | +7.5% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | -41989000.0 | -240.8% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | -55004000.0 | -31.0% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | -34648000.0 | +37.0% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | -359430000.0 | -937.4% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | -239405000.0 | +33.4% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | -380089000.0 | -58.8% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | -518700000.0 | -36.5% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -485100000.0 | +6.5% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | -1141800000.0 | -135.4% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | -95400000.0 | +91.6% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | -47700000.0 | +50.0% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | -107900000.0 | -126.2% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | -294700000.0 | -173.1% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | -277400000.0 | +5.9% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | -442400000.0 | -59.5% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | -357500000.0 | +19.2% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -716100000.0 | -100.3% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | -1103600000.0 | -54.1% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | -680400000.0 | +38.3% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | -1029600000.0 | -51.3% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | -2184100000.0 | -112.1% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 133271000.0 | — | USD | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 68404000.0 | -48.7% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | -71219000.0 | -204.1% | USD | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 126800000.0 | +278.0% | USD | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | -505300000.0 | -498.5% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | -1478000000.0 | -192.5% | USD | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | -67700000.0 | +95.4% | USD | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | -562200000.0 | -730.4% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -1494900000.0 | -165.9% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | -2261300000.0 | -51.3% | USD | 10-K | 2026-02-13 |
Capital Expenditures
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 11974000.0 | — | USD | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 27892000.0 | +132.9% | USD | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 41775000.0 | +49.8% | USD | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 11099000.0 | -73.4% | USD | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 28477000.0 | +156.6% | USD | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 56437000.0 | +98.2% | USD | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 29279000.0 | -48.1% | USD | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 58891000.0 | +101.1% | USD | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 79803000.0 | +35.5% | USD | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 18041000.0 | -77.4% | USD | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 34399000.0 | +90.7% | USD | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 58690000.0 | +70.6% | USD | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 19450000.0 | -66.9% | USD | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 37314000.0 | +91.8% | USD | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 212109000.0 | +468.4% | USD | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 70900000.0 | -66.6% | USD | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 120800000.0 | +70.4% | USD | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 173200000.0 | +43.4% | USD | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 63600000.0 | -63.3% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 116900000.0 | +83.8% | USD | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 171100000.0 | +46.4% | USD | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 42100000.0 | -75.4% | USD | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 101700000.0 | +141.6% | USD | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 142300000.0 | +39.9% | USD | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 68400000.0 | -51.9% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 137400000.0 | +100.9% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 205100000.0 | +49.3% | USD | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 40700000.0 | -80.2% | USD | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 186400000.0 | +358.0% | USD | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 288200000.0 | +54.6% | USD | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 56563000.0 | — | USD | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 99421000.0 | +75.8% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 95449000.0 | -4.0% | USD | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 75400000.0 | -21.0% | USD | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 259800000.0 | +244.6% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 235000000.0 | -9.5% | USD | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 204700000.0 | -12.9% | USD | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 200400000.0 | -2.1% | USD | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 297700000.0 | +48.6% | USD | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 437600000.0 | +47.0% | USD | 10-K | 2026-02-13 |
Share Data
Metrics: 4Shares Outstanding
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 247286705.0 | — | shares | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 247703932.0 | +0.2% | shares | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 248028962.0 | +0.1% | shares | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 248300517.0 | +0.1% | shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 248890834.0 | +0.2% | shares | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 250769906.0 | +0.8% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 252683346.0 | +0.8% | shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 253253362.0 | +0.2% | shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 254867865.0 | +0.6% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 254882837.0 | +0.0% | shares | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 255610812.0 | +0.3% | shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 255172000.0 | -0.2% | shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 256351000.0 | +0.5% | shares | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 256671000.0 | +0.1% | shares | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 257265000.0 | +0.2% | shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 258993000.0 | +0.7% | shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 259079000.0 | +0.0% | shares | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 260124000.0 | +0.4% | shares | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 260174000.0 | +0.0% | shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 259890000.0 | -0.1% | shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 258829000.0 | -0.4% | shares | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 259114000.0 | +0.1% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 256206000.0 | -1.1% | shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 254479046.0 | -0.7% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 255574961.0 | +0.4% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 256026201.0 | +0.2% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 256645737.0 | +0.2% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 257011628.0 | +0.1% | shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 257509761.0 | +0.2% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 257792648.0 | +0.1% | shares | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 257828508.0 | +0.0% | shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 257695221.0 | -0.1% | shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 258296249.0 | +0.2% | shares | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 258015301.0 | -0.1% | shares | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 257739599.0 | -0.1% | shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 256940382.0 | -0.3% | shares | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 256967767.0 | +0.0% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 256293058.0 | -0.3% | shares | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 253951475.0 | -0.9% | shares | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 248300517.0 | — | shares | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 253253362.0 | +2.0% | shares | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 255172000.0 | +0.8% | shares | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 258993000.0 | +1.5% | shares | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 259889549.0 | +0.3% | shares | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 254479046.0 | -2.1% | shares | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 257011628.0 | +1.0% | shares | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 257695221.0 | +0.3% | shares | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 256940382.0 | -0.3% | shares | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 253991224.0 | -1.1% | shares | 10-K | 2026-02-13 |
Shares Issued
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 247286705.0 | — | shares | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 247703932.0 | +0.2% | shares | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 248028962.0 | +0.1% | shares | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 248300517.0 | +0.1% | shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 248890834.0 | +0.2% | shares | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 250769906.0 | +0.8% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 252683346.0 | +0.8% | shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 253253362.0 | +0.2% | shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 254934949.0 | +0.7% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 254882837.0 | -0.0% | shares | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 255610812.0 | +0.3% | shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 255172000.0 | -0.2% | shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 256351000.0 | +0.5% | shares | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 256671000.0 | +0.1% | shares | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 257265000.0 | +0.2% | shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 258993000.0 | +0.7% | shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 259079000.0 | +0.0% | shares | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 260124000.0 | +0.4% | shares | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 260174000.0 | +0.0% | shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 259890000.0 | -0.1% | shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 258829000.0 | -0.4% | shares | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 259114000.0 | +0.1% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 256206000.0 | -1.1% | shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 254479046.0 | -0.7% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 255574961.0 | +0.4% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 256026201.0 | +0.2% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 256645737.0 | +0.2% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 257011628.0 | +0.1% | shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 257509761.0 | +0.2% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 257792648.0 | +0.1% | shares | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 257828508.0 | +0.0% | shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 257695221.0 | -0.1% | shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 258296249.0 | +0.2% | shares | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 258015301.0 | -0.1% | shares | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 257739599.0 | -0.1% | shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 256940382.0 | -0.3% | shares | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 256967767.0 | +0.0% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 256293058.0 | -0.3% | shares | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 253951475.0 | -0.9% | shares | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 248300517.0 | — | shares | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 253253362.0 | +2.0% | shares | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 255172000.0 | +0.8% | shares | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 258993000.0 | +1.5% | shares | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 259889549.0 | +0.3% | shares | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 254479046.0 | -2.1% | shares | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 257011628.0 | +1.0% | shares | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 257695221.0 | +0.3% | shares | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 256940382.0 | -0.3% | shares | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 253991224.0 | -1.1% | shares | 10-K | 2026-02-13 |
Weighted Avg Shares Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 243831000.0 | — | shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 244482000.0 | +0.3% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 244920000.0 | +0.2% | shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 246024000.0 | +0.5% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 247521000.0 | +0.6% | shares | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 250268000.0 | +1.1% | shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 253231000.0 | +1.2% | shares | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 254135000.0 | +0.4% | shares | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 254905000.0 | +0.3% | shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 255695000.0 | +0.3% | shares | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 256154000.0 | +0.2% | shares | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 256946000.0 | +0.3% | shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 259815000.0 | +1.1% | shares | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 259637000.0 | -0.1% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 260392000.0 | +0.3% | shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 259400000.0 | -0.4% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 259000000.0 | -0.2% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 257900000.0 | -0.4% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 255100000.0 | -1.1% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 255900000.0 | +0.3% | shares | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 256500000.0 | +0.2% | shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 257400000.0 | +0.4% | shares | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 257700000.0 | +0.1% | shares | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 258000000.0 | +0.1% | shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 258200000.0 | +0.1% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 258100000.0 | -0.0% | shares | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 258000000.0 | -0.0% | shares | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 256900000.0 | -0.4% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 256700000.0 | -0.1% | shares | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 255600000.0 | -0.4% | shares | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 244685000.0 | — | shares | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 248858000.0 | +1.7% | shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 254292000.0 | +2.2% | shares | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 256700000.0 | +0.9% | shares | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 259800000.0 | +1.2% | shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 257700000.0 | -0.8% | shares | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 256100000.0 | -0.6% | shares | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 257700000.0 | +0.6% | shares | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 257900000.0 | +0.1% | shares | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 255700000.0 | -0.9% | shares | 10-K | 2026-02-13 |
Weighted Avg Shares Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 243831000.0 | — | shares | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 244482000.0 | +0.3% | shares | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 244920000.0 | +0.2% | shares | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 248700000.0 | +1.5% | shares | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 251635000.0 | +1.2% | shares | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 250268000.0 | -0.5% | shares | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 258526000.0 | +3.3% | shares | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 258584000.0 | +0.0% | shares | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 259788000.0 | +0.5% | shares | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 260175000.0 | +0.1% | shares | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 259822000.0 | -0.1% | shares | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 260473000.0 | +0.3% | shares | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 263515000.0 | +1.2% | shares | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 263403000.0 | -0.0% | shares | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 264079000.0 | +0.3% | shares | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 261900000.0 | -0.8% | shares | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 261000000.0 | -0.3% | shares | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 259700000.0 | -0.5% | shares | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 257900000.0 | -0.7% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 258700000.0 | +0.3% | shares | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 259500000.0 | +0.3% | shares | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 260300000.0 | +0.3% | shares | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 260400000.0 | +0.0% | shares | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 260600000.0 | +0.1% | shares | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 261100000.0 | +0.2% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 258100000.0 | -1.1% | shares | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 261000000.0 | +1.1% | shares | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 259500000.0 | -0.6% | shares | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 258900000.0 | -0.2% | shares | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 257600000.0 | -0.5% | shares | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 244685000.0 | — | shares | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 253225000.0 | +3.5% | shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 259185000.0 | +2.4% | shares | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 260700000.0 | +0.6% | shares | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 263400000.0 | +1.0% | shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 259900000.0 | -1.3% | shares | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 259100000.0 | -0.3% | shares | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 260500000.0 | +0.5% | shares | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 257900000.0 | -1.0% | shares | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 258000000.0 | +0.0% | shares | 10-K | 2026-02-13 |
Credit and Bond Coverage
Company-levelMetrics
Metrics: 8Asset Turnover
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1600 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 0.1693 | +5.8% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 0.1586 | -6.4% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 0.2425 | +53.0% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.1656 | -31.7% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 0.1808 | +9.2% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.1621 | -10.3% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 0.1735 | +7.0% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 0.1698 | -2.1% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 0.1312 | -22.7% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 0.1338 | +2.0% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 0.1264 | -5.6% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 0.1704 | +34.8% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 0.1492 | -12.4% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.1361 | -8.8% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 0.1423 | +4.6% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 0.1467 | +3.1% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 0.1572 | +7.2% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.1471 | -6.4% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.1409 | -4.2% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 0.1397 | -0.9% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 0.1252 | -10.4% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 0.1225 | -2.1% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 0.1143 | -6.7% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 0.1125 | -1.6% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 0.1314 | +16.8% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 0.1246 | -5.2% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 0.1211 | -2.9% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.1233 | +1.9% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 0.1237 | +0.3% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 0.5876 | — | ratio | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 0.7018 | +19.4% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.4879 | -30.5% | ratio | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 0.5004 | +2.6% | ratio | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 0.5281 | +5.5% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.5639 | +6.8% | ratio | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 0.4920 | -12.7% | ratio | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 0.4342 | -11.8% | ratio | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 0.4891 | +12.6% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 0.4680 | -4.3% | ratio | 10-K | 2026-02-13 |
Current Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 2.5412 | — | ratio | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 2.3347 | -8.1% | ratio | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 2.0778 | -11.0% | ratio | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 2.3110 | +11.2% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 3.8216 | +65.4% | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 3.4867 | -8.8% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 3.2754 | -6.1% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 3.2814 | +0.2% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 3.6759 | +12.0% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 3.6746 | -0.0% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 3.7144 | +1.1% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 3.4305 | -7.6% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 3.7805 | +10.2% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 3.7412 | -1.0% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 3.4395 | -8.1% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 3.6131 | +5.0% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 3.5395 | -2.0% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 3.7219 | +5.2% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 3.7217 | -0.0% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 4.3319 | +16.4% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 4.3925 | +1.4% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 4.6054 | +4.8% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 4.6245 | +0.4% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 4.4634 | -3.5% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 4.7525 | +6.5% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 4.5002 | -5.3% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 4.7028 | +4.5% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 4.8265 | +2.6% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 4.2845 | -11.2% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 4.1386 | -3.4% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 4.0828 | -1.3% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 3.9872 | -2.3% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 3.5008 | -12.2% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 2.5207 | -28.0% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 2.4676 | -2.1% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 2.6921 | +9.1% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 2.6456 | -1.7% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 2.5198 | -4.8% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 2.3618 | -6.3% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 2.3110 | — | ratio | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 3.2814 | +42.0% | ratio | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 3.4305 | +4.5% | ratio | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 3.6131 | +5.3% | ratio | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 4.3320 | +19.9% | ratio | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 4.4634 | +3.0% | ratio | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 4.8265 | +8.1% | ratio | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 3.9872 | -17.4% | ratio | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 2.6921 | -32.5% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 2.9009 | +7.8% | ratio | 10-K | 2026-02-13 |
Debt to Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1.2289 | — | ratio | 10-Q | 2016-05-03 |
| Quarterly | 2016-06-30 | 1.1808 | -3.9% | ratio | 10-Q | 2016-08-01 |
| Quarterly | 2016-09-30 | 1.1597 | -1.8% | ratio | 10-Q | 2016-10-31 |
| Quarterly | 2016-12-31 | 1.1647 | +0.4% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 0.7511 | -35.5% | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2017-06-30 | 0.7596 | +1.1% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2017-09-30 | 0.7737 | +1.8% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-12-31 | 0.7363 | -4.8% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.6262 | -15.0% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2018-06-30 | 0.5969 | -4.7% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2018-09-30 | 0.5747 | -3.7% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-12-31 | 0.4083 | -29.0% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 0.3853 | -5.6% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2019-06-30 | 0.3873 | +0.5% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2019-09-30 | 0.4304 | +11.1% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-12-31 | 0.3670 | -14.7% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 0.3763 | +2.5% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2020-06-30 | 0.3587 | -4.7% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2020-09-30 | 0.3895 | +8.6% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-12-31 | 0.3528 | -9.4% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 0.3491 | -1.1% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2021-06-30 | 0.3290 | -5.8% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2021-09-30 | 0.3240 | -1.5% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-12-31 | 0.3300 | +1.8% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.3071 | -6.9% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2022-06-30 | 0.3058 | -0.4% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2022-09-30 | 0.2822 | -7.7% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-12-31 | 0.3046 | +8.0% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 0.3147 | +3.3% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 0.3154 | +0.2% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2023-09-30 | 0.3157 | +0.1% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-12-31 | 0.2929 | -7.2% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 0.2896 | -1.1% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2024-06-30 | 0.3626 | +25.2% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2024-09-30 | 0.4228 | +16.6% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-12-31 | 0.3732 | -11.7% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 0.3870 | +3.7% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.3995 | +3.2% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 0.4356 | +9.0% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 1.1647 | — | ratio | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 0.7363 | -36.8% | ratio | 10-K | 2019-02-13 |
| Annual | 2018-12-31 | 0.4083 | -44.6% | ratio | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 0.3670 | -10.1% | ratio | 10-K | 2021-02-11 |
| Annual | 2020-12-31 | 0.3528 | -3.9% | ratio | 10-K | 2022-02-09 |
| Annual | 2021-12-31 | 0.3300 | -6.5% | ratio | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 0.3046 | -7.7% | ratio | 10-K | 2024-02-15 |
| Annual | 2023-12-31 | 0.2929 | -3.8% | ratio | 10-K | 2025-02-13 |
| Annual | 2024-12-31 | 0.3732 | +27.4% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 0.3738 | +0.2% | ratio | 10-K | 2026-02-13 |
Net Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.0907 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | -0.0838 | +7.6% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -0.0956 | -14.1% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 0.3492 | +465.4% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.0573 | -83.6% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -0.5038 | -979.5% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.3547 | +170.4% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 0.2742 | -22.7% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 0.1637 | -40.3% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 0.3129 | +91.1% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 0.2841 | -9.2% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 0.0606 | -78.7% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 0.3978 | +557.0% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 0.5492 | +38.1% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.4339 | -21.0% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 0.3788 | -12.7% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 0.0374 | -90.1% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 0.4294 | +1049.3% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.3633 | -15.4% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.3690 | +1.6% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 0.3986 | +8.0% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 0.2947 | -26.1% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 0.3673 | +24.6% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 0.4169 | +13.5% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 0.4087 | -2.0% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -1.3583 | -432.4% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 0.3771 | +127.8% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 0.2333 | -38.1% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.3484 | +49.3% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 0.3520 | +1.0% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | -0.0494 | — | ratio | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 0.0368 | +174.6% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.6848 | +1759.9% | ratio | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 0.2827 | -58.7% | ratio | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 0.4370 | +54.6% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.3092 | -29.2% | ratio | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 0.3720 | +20.3% | ratio | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 0.3668 | -1.4% | ratio | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -0.0486 | -113.3% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 0.3294 | +777.7% | ratio | 10-K | 2026-02-13 |
Operating Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.0360 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 0.0078 | +121.6% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -0.0453 | -682.6% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 0.3789 | +937.3% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.0969 | -74.4% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -0.5639 | -682.2% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.2012 | +135.7% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 0.2298 | +14.3% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 0.2621 | +14.0% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 0.3225 | +23.0% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 0.2868 | -11.1% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 0.1046 | -63.5% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 0.4754 | +354.5% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 0.4710 | -0.9% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.4370 | -7.2% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 0.5149 | +17.8% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | -0.0211 | -104.1% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 0.5315 | +2614.9% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.4963 | -6.6% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.5037 | +1.5% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 0.4827 | -4.2% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 0.3280 | -32.0% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 0.4117 | +25.5% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 0.4180 | +1.5% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 0.4235 | +1.3% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -1.3285 | -413.7% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 0.4027 | +130.3% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 0.2275 | -43.5% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.3883 | +70.7% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 0.3856 | -0.7% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 0.0058 | — | ratio | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 0.0495 | +748.4% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.2084 | +320.8% | ratio | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 0.2877 | +38.0% | ratio | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 0.4603 | +60.0% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.3673 | -20.2% | ratio | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 0.4823 | +31.3% | ratio | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 0.3883 | -19.5% | ratio | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -0.0211 | -105.4% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 0.3477 | +1745.4% | ratio | 10-K | 2026-02-13 |
Quick Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1.0946 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | 0.9727 | -11.1% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | 0.9956 | +2.4% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2016-12-31 | 1.4939 | +50.0% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2017-03-31 | 2.0492 | +37.2% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 1.9557 | -4.6% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | 1.9486 | -0.4% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2017-12-31 | 2.0630 | +5.9% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2018-03-31 | 2.4125 | +16.9% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 2.3136 | -4.1% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 2.4970 | +7.9% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2018-12-31 | 2.3656 | -5.3% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2019-03-31 | 2.6154 | +10.6% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 2.6164 | +0.0% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 2.4465 | -6.5% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2019-12-31 | 2.3294 | -4.8% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2020-03-31 | 2.3353 | +0.3% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 2.6861 | +15.0% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 2.6737 | -0.5% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2020-12-31 | 3.1894 | +19.3% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2021-03-31 | 3.2429 | +1.7% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 3.3019 | +1.8% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 3.2784 | -0.7% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2021-12-31 | 3.1723 | -3.2% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2022-03-31 | 3.4860 | +9.9% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 3.4044 | -2.3% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 3.5149 | +3.2% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2022-12-31 | 3.8306 | +9.0% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2023-03-31 | 3.0698 | -19.9% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 3.0283 | -1.4% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 3.0867 | +1.9% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2023-12-31 | 2.9230 | -5.3% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2024-03-31 | 2.4126 | -17.5% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | 1.2912 | -46.5% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 1.3187 | +2.1% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2024-12-31 | 1.2819 | -2.8% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 1.2356 | -3.6% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 1.2015 | -2.8% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 1.1037 | -8.1% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | 1.4939 | — | ratio | 10-K | 2020-02-13 |
| Annual | 2017-12-31 | 2.0630 | +38.1% | ratio | 10-K | 2021-02-11 |
| Annual | 2018-12-31 | 2.3655 | +14.7% | ratio | 10-K | 2022-02-09 |
| Annual | 2019-12-31 | 2.3294 | -1.5% | ratio | 10-K | 2023-02-10 |
| Annual | 2020-12-31 | 3.1895 | +36.9% | ratio | 10-K | 2024-02-15 |
| Annual | 2021-12-31 | 3.1723 | -0.5% | ratio | 10-K | 2025-02-13 |
| Annual | 2022-12-31 | 3.8306 | +20.8% | ratio | 10-K | 2026-02-13 |
| Annual | 2023-12-31 | 2.9230 | -23.7% | ratio | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | 1.2819 | -56.1% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 1.3169 | +2.7% | ratio | 10-K | 2026-02-13 |
ROA
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.0145 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | -0.0142 | +2.3% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -0.0152 | -6.8% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 0.0847 | +659.0% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.0095 | -88.8% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -0.0911 | -1060.0% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.0575 | +163.1% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 0.0476 | -17.3% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 0.0278 | -41.6% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 0.0411 | +47.7% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 0.0380 | -7.4% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 0.0077 | -79.9% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 0.0678 | +785.5% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 0.0820 | +20.9% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.0591 | -27.9% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 0.0539 | -8.7% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 0.0055 | -89.8% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 0.0675 | +1131.5% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.0535 | -20.8% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.0520 | -2.7% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 0.0557 | +7.1% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 0.0369 | -33.8% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 0.0450 | +22.0% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 0.0477 | +5.9% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 0.0460 | -3.5% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -0.1785 | -488.3% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 0.0470 | +126.3% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 0.0282 | -39.9% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.0430 | +52.1% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 0.0436 | +1.4% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | -0.0290 | — | ratio | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 0.0258 | +189.1% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.3342 | +1193.1% | ratio | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 0.1415 | -57.7% | ratio | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 0.2307 | +63.1% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.1744 | -24.4% | ratio | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 0.1830 | +5.0% | ratio | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 0.1592 | -13.0% | ratio | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -0.0238 | -114.9% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 0.1542 | +748.6% | ratio | 10-K | 2026-02-13 |
ROE
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -0.0323 | — | ratio | 10-Q | 2017-04-28 |
| Quarterly | 2016-06-30 | -0.0309 | +4.4% | ratio | 10-Q | 2017-07-28 |
| Quarterly | 2016-09-30 | -0.0327 | -5.8% | ratio | 10-Q | 2017-10-30 |
| Quarterly | 2017-03-31 | 0.1483 | +553.2% | ratio | 10-Q | 2018-04-27 |
| Quarterly | 2017-06-30 | 0.0167 | -88.7% | ratio | 10-Q | 2018-07-26 |
| Quarterly | 2017-09-30 | -0.1615 | -1067.6% | ratio | 10-Q | 2018-10-25 |
| Quarterly | 2018-03-31 | 0.0935 | +157.9% | ratio | 10-Q | 2019-05-01 |
| Quarterly | 2018-06-30 | 0.0760 | -18.8% | ratio | 10-Q | 2019-08-01 |
| Quarterly | 2018-09-30 | 0.0438 | -42.4% | ratio | 10-Q | 2019-10-31 |
| Quarterly | 2019-03-31 | 0.0569 | +29.9% | ratio | 10-Q | 2020-05-01 |
| Quarterly | 2019-06-30 | 0.0527 | -7.3% | ratio | 10-Q | 2020-07-31 |
| Quarterly | 2019-09-30 | 0.0109 | -79.2% | ratio | 10-Q | 2020-10-30 |
| Quarterly | 2020-03-31 | 0.0933 | +752.0% | ratio | 10-Q | 2021-04-30 |
| Quarterly | 2020-06-30 | 0.1114 | +19.4% | ratio | 10-Q | 2021-07-30 |
| Quarterly | 2020-09-30 | 0.0821 | -26.3% | ratio | 10-Q | 2021-11-03 |
| Quarterly | 2021-03-31 | 0.0727 | -11.4% | ratio | 10-Q | 2022-05-06 |
| Quarterly | 2021-06-30 | 0.0073 | -90.0% | ratio | 10-Q | 2022-08-05 |
| Quarterly | 2021-09-30 | 0.0894 | +1126.9% | ratio | 10-Q | 2022-10-28 |
| Quarterly | 2022-03-31 | 0.0699 | -21.8% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.0679 | -2.8% | ratio | 10-Q | 2023-08-02 |
| Quarterly | 2022-09-30 | 0.0714 | +5.1% | ratio | 10-Q | 2023-11-07 |
| Quarterly | 2023-03-31 | 0.0485 | -32.1% | ratio | 10-Q | 2024-05-07 |
| Quarterly | 2023-06-30 | 0.0592 | +22.1% | ratio | 10-Q | 2024-08-02 |
| Quarterly | 2023-09-30 | 0.0627 | +5.9% | ratio | 10-Q | 2024-11-05 |
| Quarterly | 2024-03-31 | 0.0593 | -5.4% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2024-06-30 | -0.2432 | -510.2% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2024-09-30 | 0.0669 | +127.5% | ratio | 10-Q | 2025-11-04 |
| Quarterly | 2025-03-31 | 0.0392 | -41.4% | ratio | 10-Q | 2025-05-06 |
| Quarterly | 2025-06-30 | 0.0601 | +53.5% | ratio | 10-Q | 2025-08-05 |
| Quarterly | 2025-09-30 | 0.0625 | +4.0% | ratio | 10-Q | 2025-11-04 |
| Annual | 2016-12-31 | -0.0628 | — | ratio | 10-K | 2019-02-13 |
| Annual | 2017-12-31 | 0.0449 | +171.5% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.4706 | +948.8% | ratio | 10-K | 2021-02-11 |
| Annual | 2019-12-31 | 0.1934 | -58.9% | ratio | 10-K | 2022-02-09 |
| Annual | 2020-12-31 | 0.3122 | +61.4% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.2319 | -25.7% | ratio | 10-K | 2024-02-15 |
| Annual | 2022-12-31 | 0.2388 | +3.0% | ratio | 10-K | 2025-02-13 |
| Annual | 2023-12-31 | 0.2059 | -13.8% | ratio | 10-K | 2026-02-13 |
| Annual | 2024-12-31 | -0.0326 | -115.9% | ratio | 10-K | 2026-02-13 |
| Annual | 2025-12-31 | 0.2118 | +748.9% | ratio | 10-K | 2026-02-13 |
8-K Material Event Details
This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.
Event Type Distribution
Count per 8-K itemInsider Transaction History
Net Insider Flow
Monthly open-market buy value minus open-market sell valueMonthly Insider Activity Mix
Share volume split between open-market trades, grants, and exercisesTransaction Value Timeline
All Transactions
| Date | Insider | Title | Type | Security | Shares | Price | Total Value | Post-Tx Shares |
|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Liu Joy | EVP and Chief Legal Officer |
Open-market sell
S
|
Common Stock | 978 | $449.17 | $439,288 | 21,833 |
| 2026-03-27 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,329 | $450.95 | $1,050,263 | 33,076 |
| 2026-03-13 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,329 | $481.79 | $1,122,089 | 35,405 |
| 2026-03-11 | McKechnie Duncan | EVP, Chief Commercial Officer |
Open-market sell
S
|
Common Stock | 2,633 | $498.42 | $1,312,340 | 12,489 |
| 2026-03-04 | McKechnie Duncan | EVP, Chief Commercial Officer |
Open-market sell
S
|
Common Stock | 2,437 | $475.30 | $1,158,306 | 15,122 |
| 2026-03-02 | Liu Joy | EVP and Chief Legal Officer |
Open-market sell
S
|
Common Stock | 892 | $495.96 | $442,396 | 22,811 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 1,725 | $496.95 | $857,239 | 98,278 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 5,995 | $496.16 | $2,974,479 | 100,003 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 15,580 | $495.38 | $7,718,020 | 105,998 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 3,498 | $494.33 | $1,729,166 | 121,578 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 2,520 | $493.29 | $1,243,091 | 125,076 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 949 | $491.30 | $466,244 | 127,596 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 2,725 | $490.54 | $1,336,722 | 128,545 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 460 | $489.32 | $225,087 | 131,270 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 3,278 | $488.27 | $1,600,549 | 131,730 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 2,510 | $487.13 | $1,222,696 | 135,008 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 240 | $482.84 | $115,882 | 137,518 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 120 | $481.50 | $57,780 | 137,758 |
| 2026-02-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 400 | $479.75 | $191,900 | 137,878 |
| 2026-02-26 | Ambrose Kristen | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 357 | $483.36 | $172,560 | 6,624 |
| 2026-02-24 | WAGNER CHARLES F JR | EVP, CO & FO |
Other disposed transaction
F
|
Common Stock | 1,744 | $485.11 | $846,032 | 47,042 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 25,026 | $0.00 | $0 | 0 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 23,479 | $0.00 | $0 | 0 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 4,237 | $471.43 | $1,997,449 | 58,934 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 11,712 | $470.54 | $5,510,964 | 63,171 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 7,241 | $469.61 | $3,400,446 | 74,883 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 19,662 | $468.57 | $9,213,023 | 82,124 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 10,263 | $467.75 | $4,800,518 | 101,786 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 1,848 | $465.80 | $860,798 | 112,049 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 2,730 | $465.05 | $1,269,586 | 113,897 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 920 | $463.91 | $426,797 | 116,627 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Exercise / conversion
M
|
Common Stock | 25,026 | $187.53 | $4,693,126 | 117,547 |
| 2026-02-19 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Exercise / conversion
M
|
Common Stock | 23,479 | $155.57 | $3,652,628 | 92,521 |
| 2026-02-17 | WAGNER CHARLES F JR | EVP, CO & FO |
Other disposed transaction
F
|
Common Stock | 2,294 | $483.75 | $1,109,722 | 48,786 |
| 2026-02-17 | WAGNER CHARLES F JR | EVP, CO & FO |
Equity grant / award
A
|
Common Stock | 7,365 | $0.00 | $0 | 51,080 |
| 2026-02-13 | WAGNER CHARLES F JR | EVP, CO & FO |
Other disposed transaction
F
|
Common Stock | 4,565 | $487.76 | $2,226,624 | 43,715 |
| 2026-02-10 | WAGNER CHARLES F JR | EVP, CO & FO |
Other disposed transaction
F
|
Common Stock | 3,045 | $468.41 | $1,426,308 | 48,280 |
| 2026-01-22 | WAGNER CHARLES F JR | EVP, CO & FO |
Equity grant / award
A
|
Common Stock | 4,160 | $0.00 | $0 | 51,325 |
| 2026-01-22 | WAGNER CHARLES F JR | EVP, CO & FO |
Equity grant / award
A
|
Common Stock | 9,440 | $0.00 | $0 | 47,165 |
| 2026-01-15 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 80 | $443.56 | $35,625 | 2,719 |
| 2026-01-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 4,500 | $474.99 | $2,137,455 | 42,293 |
| 2026-01-06 | WAGNER CHARLES F JR | EVP, CO & FO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 9,532 | $0.00 | $0 | 0 |
| 2026-01-06 | WAGNER CHARLES F JR | EVP, CO & FO |
Open-market sell
S
|
Common Stock | 9,532 | $461.00 | $4,394,252 | 37,725 |
| 2026-01-06 | WAGNER CHARLES F JR | EVP, CO & FO |
Exercise / conversion
M
|
Common Stock | 9,532 | $189.38 | $1,805,170 | 47,257 |
| 2025-12-03 | WAGNER CHARLES F JR | EVP, CO & FO |
Open-market sell
S
|
Common Stock | 7,000 | $461.00 | $3,227,000 | 37,725 |
| 2025-11-19 | CARNEY LLOYD | Dir |
Equity grant / award
G
|
Common Stock | 800 | $0.00 | $0 | 6,315 |
| 2025-11-17 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. |
Open-market sell
S
|
Common Stock | 2,500 | $434.58 | $1,086,450 | 16,852 |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 39,769 | $0.00 | $0 | 63,781 |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 13,835 | $0.00 | $0 | 1 |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 40 | $442.00 | $17,680 | 24,026 |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 21,330 | $441.35 | $9,413,996 | 24,066 |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 32,234 | $440.30 | $14,192,630 | 45,396 |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 39,769 | $86.52 | $3,440,814 | 77,630 |
| 2025-11-14 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 13,835 | $91.05 | $1,259,677 | 37,861 |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 19,688 | $0.00 | $0 | 13,836 |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 1,160 | $441.05 | $511,618 | 24,026 |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 18,528 | $440.22 | $8,156,396 | 25,186 |
| 2025-11-13 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 19,688 | $91.05 | $1,792,592 | 43,714 |
| 2025-10-15 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 87 | $410.31 | $35,625 | 2,638 |
| 2025-10-02 | Biller Jonathan | EVP and Chief Legal Officer |
Open-market sell
S
|
Common Stock | 694 | $404.21 | $280,522 | 15,653 |
| 2025-10-01 | Biller Jonathan | EVP and Chief Legal Officer |
Other disposed transaction
F
|
Common Stock | 1,259 | $400.00 | $503,600 | 16,347 |
| 2025-08-27 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 266 | $386.69 | $102,860 | 4,565 |
| 2025-08-06 | Kewalramani Reshma | CEO & President |
Open-market buy
P
|
Common Stock | 5,710 | $389.95 | $2,226,614 | 115,968 |
| 2025-08-06 | Kewalramani Reshma | CEO & President |
Open-market buy
P
|
Common Stock | 4,290 | $389.08 | $1,669,153 | 110,258 |
| 2025-07-15 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 76 | $469.34 | $35,625 | 2,552 |
| 2025-07-01 | Arbuckle Stuart A | EVP, COO |
Other disposed transaction
F
|
Common Stock | 37,243 | $450.23 | $16,767,916 | 63,368 |
| 2025-05-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 52 | $424.69 | $22,084 | 23,281 |
| 2025-05-13 | Arbuckle Stuart A | EVP, COO |
Equity grant / award
A
|
Common Stock | 37,622 | $0.00 | $0 | 100,611 |
| 2025-05-01 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 1,001 | — | — | 2,476 |
| 2025-05-01 | Upadhyay Suketu | Dir |
Other disposed transaction
D
|
Common Stock | 1,001 | — | — | 2,354 |
| 2025-05-01 | Upadhyay Suketu | Dir |
Equity grant / award
A
|
Common Stock | 796 | $0.00 | $0 | 3,355 |
| 2025-04-15 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 72 | $497.51 | $35,625 | 1,475 |
| 2025-03-13 | ALTSHULER DAVID | EVP, Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 3,231 | $510.00 | $1,647,810 | 23,281 |
| 2025-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 3,298 | $500.00 | $1,649,000 | 51,671 |
| 2025-03-04 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 4,058 | $485.49 | $1,970,118 | 54,481 |
| 2025-03-03 | ALTSHULER DAVID | EVP, Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 3,231 | $490.00 | $1,583,190 | 29,743 |
| 2025-02-26 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 4,962 | $479.61 | $2,379,825 | 54,969 |
| 2025-02-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 3,310 | $483.28 | $1,599,657 | 59,931 |
| 2025-02-20 | ALTSHULER DAVID | EVP, Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 1,111 | $480.00 | $533,280 | 45,019 |
| 2025-02-14 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,293 | $463.46 | $1,062,714 | 63,241 |
| 2025-02-12 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 6,655 | $0.00 | $0 | 65,534 |
| 2025-02-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,649 | $467.98 | $1,239,679 | 58,879 |
| 2025-02-04 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 7,114 | $0.00 | $0 | 61,528 |
| 2025-02-04 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 10,262 | $0.00 | $0 | 54,414 |
| 2025-01-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 112 | $420.31 | $46,929 | 15,145 |
| 2024-11-15 | ALTSHULER DAVID | EVP, Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 15 | $478.56 | $7,178 | 25,813 |
| 2024-11-11 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 3,000 | $518.27 | $1,554,810 | 44,137 |
| 2024-11-08 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 15,198 | $515.00 | $7,826,970 | 75,772 |
| 2024-10-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 90 | $484.39 | $43,750 | 15,033 |
| 2024-10-02 | Biller Jonathan | EVP and Chief Legal Officer |
Open-market sell
S
|
Common Stock | 999 | $461.66 | $461,198 | 16,651 |
| 2024-10-01 | Biller Jonathan | EVP and Chief Legal Officer |
Other disposed transaction
F
|
Common Stock | 630 | $466.84 | $294,109 | 17,650 |
| 2024-08-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 3,784 | $499.00 | $1,888,216 | 9,994 |
| 2024-08-08 | Bhatia Sangeeta N. | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,292 | $0.00 | $0 | 646 |
| 2024-08-08 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 1,292 | $466.29 | $602,447 | 4,435 |
| 2024-08-08 | Bhatia Sangeeta N. | Dir |
Exercise / conversion
M
|
Common Stock | 1,292 | $152.74 | $197,340 | 5,727 |
| 2024-08-07 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,280 | $476.75 | $1,086,990 | 23,259 |
| 2024-08-01 | SACHS BRUCE I | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 5,295 | $0.00 | $0 | 0 |
| 2024-08-01 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 5,295 | $508.00 | $2,689,860 | 40,000 |
| 2024-08-01 | SACHS BRUCE I | Dir |
Exercise / conversion
M
|
Common Stock | 5,295 | $125.71 | $665,634 | 45,295 |
| 2024-07-30 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 15,202 | $505.00 | $7,677,010 | 90,970 |
| 2024-07-24 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,280 | $488.46 | $1,113,689 | 25,539 |
| 2024-07-22 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 15,202 | $497.00 | $7,555,394 | 106,172 |
| 2024-07-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 89 | $490.12 | $43,750 | 14,943 |
| 2024-07-10 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,280 | $487.34 | $1,111,135 | 27,819 |
| 2024-06-26 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,280 | $471.72 | $1,075,522 | 30,099 |
| 2024-06-12 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. |
Open-market sell
S
|
Common Stock | 7,288 | $478.00 | $3,483,664 | 15,972 |
| 2024-06-12 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,280 | $478.00 | $1,089,840 | 32,379 |
| 2024-06-11 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. |
Other disposed transaction
F
|
Common Stock | 6,824 | $481.96 | $3,288,895 | 23,260 |
| 2024-06-05 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Equity grant / award
G
|
Common Stock | 4,600 | $0.00 | $0 | 0 |
| 2024-06-03 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 3,250 | $460.00 | $1,495,000 | 47,137 |
| 2024-05-31 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 2,250 | $445.00 | $1,001,250 | 51,273 |
| 2024-05-30 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 2,350 | $439.11 | $1,031,908 | 53,523 |
| 2024-05-29 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 2,280 | $445.56 | $1,015,877 | 34,659 |
| 2024-05-28 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 3,250 | $454.79 | $1,478,068 | 50,387 |
| 2024-05-24 | Kewalramani Reshma | CEO & President |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,565 | $0.00 | $0 | 0 |
| 2024-05-24 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 1,565 | $457.00 | $715,205 | 121,374 |
| 2024-05-24 | Kewalramani Reshma | CEO & President |
Exercise / conversion
M
|
Common Stock | 1,565 | $187.53 | $293,484 | 122,939 |
| 2024-05-22 | SACHS BRUCE I | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 7,073 | $0.00 | $0 | 0 |
| 2024-05-22 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 7,073 | $448.00 | $3,168,704 | 40,000 |
| 2024-05-22 | SACHS BRUCE I | Dir |
Exercise / conversion
M
|
Common Stock | 7,073 | $93.51 | $661,396 | 47,073 |
| 2024-05-20 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 15,202 | $447.00 | $6,795,294 | 121,374 |
| 2024-05-15 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 32 | $430.93 | $13,790 | 55,325 |
| 2024-05-14 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. |
Equity grant / award
A
|
Common Stock | 14,112 | $0.00 | $0 | 30,084 |
| 2024-05-01 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 1,168 | — | — | 1,403 |
| 2024-05-01 | Upadhyay Suketu | Dir |
Other disposed transaction
D
|
Common Stock | 1,168 | — | — | 2,559 |
| 2024-05-01 | Upadhyay Suketu | Dir |
Equity grant / award
A
|
Common Stock | 1,001 | $0.00 | $0 | 3,727 |
| 2024-04-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 109 | $399.58 | $43,750 | 14,854 |
| 2024-04-02 | Ambrose Kristen | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 240 | $419.00 | $100,560 | 7,500 |
| 2024-04-01 | Ambrose Kristen | SVP & Chief Accounting Officer |
Other disposed transaction
F
|
Common Stock | 225 | $418.10 | $94,072 | 7,740 |
| 2024-02-23 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 3,309 | $431.79 | $1,428,793 | 53,583 |
| 2024-02-21 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 360 | $421.77 | $151,837 | 59,467 |
| 2024-02-20 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,812 | $420.58 | $1,182,671 | 56,892 |
| 2024-02-20 | LEIDEN JEFFREY M | Executive Chairman |
Other disposed transaction
F
|
Common Stock | 4,118 | $420.58 | $1,731,948 | 13,778 |
| 2024-02-16 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 3,750 | $424.01 | $1,590,038 | 59,704 |
| 2024-02-15 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 4,655 | $419.16 | $1,951,190 | 17,896 |
| 2024-02-14 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 4,356 | $419.04 | $1,825,338 | 22,551 |
| 2024-02-13 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 737 | $419.13 | $308,899 | 26,907 |
| 2024-02-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 647 | $420.39 | $271,992 | 27,644 |
| 2024-02-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 2,009 | $419.22 | $842,213 | 28,291 |
| 2024-02-09 | LEIDEN JEFFREY M | Executive Chairman |
Other disposed transaction
F
|
Common Stock | 8,048 | $422.74 | $3,402,212 | 30,300 |
| 2024-02-09 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,607 | $422.74 | $1,102,083 | 63,454 |
| 2024-02-08 | LEIDEN JEFFREY M | Executive Chairman |
Other disposed transaction
F
|
Common Stock | 2,698 | $421.73 | $1,137,828 | 38,348 |
| 2024-02-07 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 7,114 | $0.00 | $0 | 66,061 |
| 2024-02-06 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 9,440 | $0.00 | $0 | 58,947 |
| 2024-02-06 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 5,814 | $0.00 | $0 | 49,507 |
| 2024-01-12 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 101 | $432.99 | $43,750 | 14,744 |
| 2024-01-08 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 6,648 | $419.07 | $2,785,977 | 2,423 |
| 2024-01-02 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 3,000 | $405.00 | $1,215,000 | 43,693 |
| 2023-12-15 | Kewalramani Reshma | CEO & President |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 14,077 | $0.00 | $0 | 1,565 |
| 2023-12-15 | Kewalramani Reshma | CEO & President |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,058 | $0.00 | $0 | 0 |
| 2023-12-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 17,135 | $407.00 | $6,973,945 | 108,711 |
| 2023-12-15 | Kewalramani Reshma | CEO & President |
Exercise / conversion
M
|
Common Stock | 14,077 | $187.53 | $2,639,860 | 125,846 |
| 2023-12-15 | Kewalramani Reshma | CEO & President |
Exercise / conversion
M
|
Common Stock | 3,058 | $155.57 | $475,733 | 111,769 |
| 2023-12-13 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 100 | $400.19 | $40,019 | 9,071 |
| 2023-12-13 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 13,254 | $399.41 | $5,293,780 | 9,171 |
| 2023-12-05 | Thornberry Nancy | Dir |
Equity grant / award
A
|
Common Stock | 1,136 | $0.00 | $0 | 1,136 |
| 2023-11-20 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 3,000 | $349.88 | $1,049,640 | 46,693 |
| 2023-11-15 | Sachdev Amit | EVP Chief Patient & Ext Af Off |
Open-market sell
S
|
Common Stock | 35 | $369.92 | $12,947 | 58,814 |
| 2023-11-14 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 5,650 | $380.82 | $2,151,633 | 29,302 |
| 2023-11-13 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 5,097 | $377.00 | $1,921,569 | 113,809 |
| 2023-11-06 | SACHS BRUCE I | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 11,250 | $0.00 | $0 | 11,250 |
| 2023-11-06 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 11,250 | $385.00 | $4,331,250 | 40,000 |
| 2023-11-06 | SACHS BRUCE I | Dir |
Exercise / conversion
M
|
Common Stock | 11,250 | $127.54 | $1,434,825 | 51,250 |
| 2023-10-31 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 5,651 | $355.92 | $2,011,304 | 34,952 |
| 2023-10-17 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 5,651 | $373.25 | $2,109,236 | 40,603 |
| 2023-10-16 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 12,962 | $374.00 | $4,847,788 | 22,425 |
| 2023-10-13 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 118 | $369.98 | $43,750 | 14,643 |
| 2023-10-06 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 242 | $360.00 | $87,120 | 4,144 |
| 2023-10-05 | Lagarde Michel | Dir |
Equity grant / award
A
|
Common Stock | 1,132 | $0.00 | $0 | 1,132 |
| 2023-10-03 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 5,651 | $345.28 | $1,951,177 | 46,254 |
| 2023-10-02 | Biller Jonathan | EVP and Chief Legal Officer |
Open-market sell
S
|
Common Stock | 610 | $346.76 | $211,524 | 10,569 |
| 2023-09-29 | Biller Jonathan | EVP and Chief Legal Officer |
Other disposed transaction
F
|
Common Stock | 408 | $350.72 | $143,094 | 11,179 |
| 2023-09-19 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 5,651 | $351.00 | $1,983,501 | 51,905 |
| 2023-09-05 | Bozic Carmen | EVP and CMO |
Open-market sell
S
|
Common Stock | 5,651 | $352.66 | $1,992,882 | 57,556 |
| 2023-08-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 2,500 | $355.00 | $887,500 | 48,637 |
| 2023-08-10 | Kearney Terrence C | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 10,000 | $0.00 | $0 | 10,000 |
| 2023-08-10 | Kearney Terrence C | Dir |
Open-market sell
S
|
Common Stock | 10,000 | $350.00 | $3,500,000 | 6,536 |
| 2023-08-10 | Kearney Terrence C | Dir |
Exercise / conversion
M
|
Common Stock | 10,000 | $127.54 | $1,275,400 | 16,536 |
| 2023-08-09 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 63 | $345.51 | $21,767 | 32,038 |
| 2023-07-17 | SACHS BRUCE I | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 11,250 | $0.00 | $0 | 11,250 |
| 2023-07-17 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 3,842 | $357.29 | $1,372,708 | 40,000 |
| 2023-07-17 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 5,711 | $356.75 | $2,037,399 | 43,842 |
| 2023-07-17 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 1,697 | $355.54 | $603,351 | 49,553 |
| 2023-07-17 | SACHS BRUCE I | Dir |
Exercise / conversion
M
|
Common Stock | 11,250 | $127.54 | $1,434,825 | 51,250 |
| 2023-07-17 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 7,828 | $355.00 | $2,778,940 | 118,906 |
| 2023-07-14 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 125 | $350.79 | $43,750 | 14,525 |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 8,603 | $0.00 | $0 | 8,603 |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 8,603 | $349.00 | $3,002,447 | 56,556 |
| 2023-06-15 | Arbuckle Stuart A | EVP, COO |
Exercise / conversion
M
|
Common Stock | 8,603 | $187.53 | $1,613,321 | 65,159 |
| 2023-05-30 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 82 | $329.82 | $27,045 | 56,556 |
| 2023-05-08 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 2,850 | $350.00 | $997,500 | 32,038 |
| 2023-05-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 422 | $350.03 | $147,713 | 34,888 |
| 2023-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 728 | $351.60 | $255,965 | 35,310 |
| 2023-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 2,053 | $350.44 | $719,453 | 36,038 |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 169 | $353.24 | $59,698 | 38,091 |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 42 | $351.65 | $14,769 | 38,260 |
| 2023-05-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 1,411 | $350.32 | $494,302 | 38,302 |
| 2023-05-01 | Upadhyay Suketu | Dir |
Equity grant / award
A
|
Common Stock | 1,168 | $0.00 | $0 | 2,726 |
| 2023-04-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 38 | $340.19 | $12,927 | 126,652 |
| 2023-04-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 1,668 | $339.43 | $566,169 | 126,690 |
| 2023-04-27 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 1,611 | $338.69 | $545,630 | 128,358 |
| 2023-04-14 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 131 | $332.77 | $43,750 | 14,400 |
| 2023-04-12 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 2,625 | $327.43 | $859,504 | 39,713 |
| 2023-04-12 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 4,068 | $326.45 | $1,327,999 | 42,338 |
| 2023-04-12 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 874 | $325.70 | $284,662 | 46,406 |
| 2023-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 31 | $318.68 | $9,879 | 47,280 |
| 2023-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 96 | $317.65 | $30,494 | 47,311 |
| 2023-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 90 | $316.76 | $28,508 | 47,407 |
| 2023-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 94 | $315.66 | $29,672 | 47,497 |
| 2023-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 211 | $314.22 | $66,300 | 47,591 |
| 2023-03-31 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Other disposed transaction
F
|
Common Stock | 1,466 | $313.74 | $459,943 | 47,802 |
| 2023-03-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 1,768 | $305.38 | $539,912 | 49,611 |
| 2023-03-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 16 | $301.13 | $4,818 | 51,379 |
| 2023-03-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 240 | $299.58 | $71,899 | 51,395 |
| 2023-03-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 784 | $295.43 | $231,617 | 52,235 |
| 2023-03-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 360 | $298.09 | $107,312 | 51,635 |
| 2023-03-16 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 264 | $301.07 | $79,482 | 49,268 |
| 2023-03-16 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 2,482 | $300.54 | $745,940 | 49,532 |
| 2023-03-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 62 | $296.77 | $18,400 | 53,379 |
| 2023-03-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 292 | $295.89 | $86,400 | 53,441 |
| 2023-03-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 715 | $294.52 | $210,582 | 53,733 |
| 2023-03-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 1,153 | $293.35 | $338,233 | 54,448 |
| 2023-03-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 420 | $292.41 | $122,812 | 55,061 |
| 2023-03-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 24 | $288.31 | $6,919 | 56,021 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 102 | $294.94 | $30,084 | 56,045 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 27 | $293.61 | $7,927 | 56,147 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 185 | $292.68 | $54,146 | 56,174 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 541 | $291.47 | $157,685 | 56,359 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 30 | $289.44 | $8,683 | 56,900 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 327 | $288.91 | $94,474 | 56,930 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 515 | $287.83 | $148,232 | 57,257 |
| 2023-03-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 361 | $286.64 | $103,477 | 57,772 |
| 2023-02-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 3,308 | $289.12 | $956,409 | 58,133 |
| 2023-02-22 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 200 | $296.31 | $59,262 | 66,304 |
| 2023-02-22 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 394 | $295.38 | $116,380 | 66,504 |
| 2023-02-22 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 1,378 | $294.29 | $405,532 | 66,898 |
| 2023-02-22 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 300 | $292.86 | $87,858 | 68,276 |
| 2023-02-22 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 129 | $291.84 | $37,647 | 68,576 |
| 2023-02-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 3,750 | $292.85 | $1,098,188 | 61,441 |
| 2023-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 51 | $300.58 | $15,330 | 65,445 |
| 2023-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 135 | $299.60 | $40,446 | 65,496 |
| 2023-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 43 | $297.98 | $12,813 | 65,631 |
| 2023-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 20 | $296.48 | $5,930 | 65,674 |
| 2023-02-14 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 71 | $295.89 | $21,008 | 65,694 |
| 2023-02-13 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 4,992 | $298.26 | $1,488,914 | 65,191 |
| 2023-02-13 | LEIDEN JEFFREY M | Executive Chairman |
Other disposed transaction
F
|
Common Stock | 13,344 | $298.26 | $3,979,981 | 62,079 |
| 2023-02-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,707 | $294.33 | $796,751 | 70,183 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,304 | $0.00 | $0 | 0 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 153 | $309.06 | $47,286 | 68,645 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 620 | $306.70 | $190,154 | 68,798 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 349 | $305.08 | $106,473 | 69,418 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 100 | $303.64 | $30,364 | 69,767 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 70 | $302.00 | $21,140 | 69,867 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 12 | $300.39 | $3,605 | 69,937 |
| 2023-02-06 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M
|
Common Stock | 1,304 | $187.53 | $244,539 | 69,949 |
| 2023-02-01 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 9,440 | $0.00 | $0 | 72,890 |
| 2023-02-01 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 10,262 | $0.00 | $0 | 63,450 |
| 2023-02-01 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 10,324 | $0.00 | $0 | 53,188 |
| 2023-01-31 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 106 | $325.00 | $34,450 | 37,998 |
| 2023-01-30 | CARNEY LLOYD | Dir |
Open-market sell
S
|
Common Stock | 324 | $321.84 | $104,276 | 4,150 |
| 2023-01-30 | CARNEY LLOYD | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $320.70 | $320,700 | 4,474 |
| 2023-01-30 | CARNEY LLOYD | Dir |
Open-market sell
S
|
Common Stock | 1,376 | $320.08 | $440,430 | 5,474 |
| 2023-01-27 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,429 | $0.00 | $0 | 0 |
| 2023-01-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 80 | $323.33 | $25,866 | 1,875 |
| 2023-01-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 970 | $322.20 | $312,534 | 1,955 |
| 2023-01-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 379 | $321.31 | $121,776 | 2,925 |
| 2023-01-27 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 1,429 | $72.14 | $103,088 | 3,304 |
| 2023-01-26 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,000 | $0.00 | $0 | 1,429 |
| 2023-01-26 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 680 | $320.94 | $218,239 | 1,875 |
| 2023-01-26 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 400 | $320.25 | $128,100 | 2,555 |
| 2023-01-26 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 478 | $319.25 | $152,602 | 2,955 |
| 2023-01-26 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $317.95 | $317,950 | 3,433 |
| 2023-01-26 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,140 | $316.82 | $361,175 | 4,433 |
| 2023-01-26 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 302 | $315.42 | $95,257 | 5,573 |
| 2023-01-26 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 4,000 | $72.14 | $288,560 | 5,875 |
| 2023-01-25 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,000 | $0.00 | $0 | 5,429 |
| 2023-01-25 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 579 | $314.95 | $182,356 | 1,875 |
| 2023-01-25 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 2,621 | $314.10 | $823,256 | 2,454 |
| 2023-01-25 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 800 | $312.80 | $250,240 | 5,075 |
| 2023-01-25 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 4,000 | $72.14 | $288,560 | 5,875 |
| 2023-01-24 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,000 | $0.00 | $0 | 9,429 |
| 2023-01-24 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,489 | $313.36 | $466,593 | 1,875 |
| 2023-01-24 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 2,511 | $312.29 | $784,160 | 3,364 |
| 2023-01-24 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 4,000 | $72.14 | $288,560 | 5,875 |
| 2023-01-23 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,129 | $0.00 | $0 | 13,429 |
| 2023-01-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 2,129 | $312.02 | $664,291 | 1,875 |
| 2023-01-23 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,129 | $72.14 | $153,586 | 4,004 |
| 2023-01-18 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 442 | $0.00 | $0 | 15,558 |
| 2023-01-18 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 442 | $312.17 | $137,979 | 1,875 |
| 2023-01-18 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 442 | $72.14 | $31,886 | 2,317 |
| 2023-01-17 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,000 | $0.00 | $0 | 16,000 |
| 2023-01-17 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 4,000 | $312.03 | $1,248,120 | 1,875 |
| 2023-01-17 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 4,000 | $72.14 | $288,560 | 5,875 |
| 2023-01-13 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 96 | $298.42 | $28,750 | 235 |
| 2022-12-06 | Arbuckle Stuart A | EVP, COO |
Equity grant / award
A
|
Common Stock | 12,753 | $0.00 | $0 | 58,031 |
| 2022-11-15 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 34 | $308.61 | $10,493 | 36,077 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,303 | $0.00 | $0 | 1,304 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 83 | $306.57 | $25,445 | 36,077 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 280 | $304.58 | $85,282 | 36,300 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 261 | $303.21 | $79,138 | 36,580 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 189 | $301.99 | $57,076 | 36,841 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 210 | $300.96 | $63,202 | 37,030 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 140 | $305.39 | $42,755 | 36,160 |
| 2022-11-07 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M
|
Common Stock | 1,303 | $187.53 | $244,352 | 37,380 |
| 2022-11-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 22 | $317.77 | $6,991 | 38,104 |
| 2022-11-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 10 | $315.68 | $3,157 | 38,126 |
| 2022-11-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 12 | $314.43 | $3,773 | 38,136 |
| 2022-11-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 81 | $313.37 | $25,383 | 38,148 |
| 2022-11-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 100 | $312.40 | $31,240 | 38,229 |
| 2022-11-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 39 | $311.17 | $12,136 | 38,329 |
| 2022-11-02 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 56 | $310.10 | $17,366 | 38,368 |
| 2022-11-01 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Other disposed transaction
F
|
Common Stock | 768 | $312.84 | $240,261 | 38,424 |
| 2022-10-24 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 621 | $310.00 | $192,510 | 4,040 |
| 2022-10-18 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 288 | $301.84 | $86,930 | 39,192 |
| 2022-10-18 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 1,503 | $300.02 | $450,930 | 39,480 |
| 2022-10-14 | Upadhyay Suketu | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 97 | $296.82 | $28,750 | 139 |
| 2022-09-19 | Biller Jonathan | EVP and Chief Legal Officer |
Equity grant / award
A
|
Common Stock | 5,294 | $0.00 | $0 | 5,294 |
| 2022-08-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 11,689 | $305.06 | $3,565,846 | 99,598 |
| 2022-08-10 | Arbuckle Stuart A | EVP, COO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 64 | $0.00 | $0 | 6,571 |
| 2022-08-10 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 9 | $302.01 | $2,718 | 60,880 |
| 2022-08-10 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 171 | $300.32 | $51,355 | 60,889 |
| 2022-08-10 | Arbuckle Stuart A | EVP, COO |
Exercise / conversion
M
|
Common Stock | 64 | $155.57 | $9,956 | 61,060 |
| 2022-08-09 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 946 | $300.00 | $283,800 | 13,388 |
| 2022-08-08 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 47 | $295.53 | $13,890 | 4,661 |
| 2022-08-08 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 161 | $294.24 | $47,373 | 4,708 |
| 2022-08-08 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 204 | $293.15 | $59,803 | 4,869 |
| 2022-08-08 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 164 | $291.76 | $47,849 | 5,073 |
| 2022-08-08 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 45 | $290.18 | $13,058 | 5,237 |
| 2022-08-01 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Other disposed transaction
F
|
Common Stock | 766 | $276.62 | $211,891 | 40,983 |
| 2022-07-29 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 5 | $282.34 | $1,412 | 5,282 |
| 2022-07-29 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 58 | $281.03 | $16,300 | 5,287 |
| 2022-07-29 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 160 | $279.28 | $44,685 | 5,444 |
| 2022-07-29 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 200 | $277.95 | $55,590 | 5,604 |
| 2022-07-29 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 99 | $280.22 | $27,742 | 5,345 |
| 2022-07-25 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 60,342 | $0.00 | $0 | 33,524 |
| 2022-07-25 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 10,471 | $283.42 | $2,967,691 | 2,423 |
| 2022-07-25 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 40,666 | $282.43 | $11,485,298 | 12,894 |
| 2022-07-25 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 34,090 | $281.27 | $9,588,494 | 53,560 |
| 2022-07-25 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 32,983 | $280.37 | $9,247,444 | 87,650 |
| 2022-07-25 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 13,869 | $279.44 | $3,875,553 | 120,633 |
| 2022-07-25 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 60,342 | $91.05 | $5,494,139 | 134,502 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 7,338 | $0.00 | $0 | 0 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 10,427 | $0.00 | $0 | 3,911 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 6,604 | $289.48 | $1,911,726 | 36,077 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 5,737 | $288.67 | $1,656,100 | 42,681 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 4,561 | $287.83 | $1,312,793 | 48,418 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 963 | $286.72 | $276,111 | 52,979 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M
|
Common Stock | 7,338 | $155.57 | $1,141,573 | 53,942 |
| 2022-07-19 | ALTSHULER DAVID | EVP, Global Research and CSO |
Exercise / conversion
M
|
Common Stock | 10,427 | $187.53 | $1,955,375 | 46,604 |
| 2022-07-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 151 | $289.23 | $43,750 | 13,975 |
| 2022-06-24 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 11,689 | $291.30 | $3,405,006 | 111,153 |
| 2022-05-31 | Bozic Carmen | EVP and CMO |
Other disposed transaction
F
|
Common Stock | 311 | $271.24 | $84,356 | 49,512 |
| 2022-05-18 | Upadhyay Suketu | Dir |
Equity grant / award
A
|
Common Stock | 1,558 | $0.00 | $0 | 1,558 |
| 2022-05-16 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 15 | $253.99 | $3,810 | 41,757 |
| 2022-05-16 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 8 | $254.44 | $2,036 | 41,749 |
| 2022-05-16 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 7 | $252.43 | $1,767 | 41,772 |
| 2022-05-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 36 | $275.09 | $9,903 | 41,660 |
| 2022-05-02 | Arbuckle Stuart A | EVP, COO |
Open-market sell
S
|
Common Stock | 306 | $263.98 | $80,778 | 64,760 |
| 2022-05-01 | Kearney Terrence C | Dir |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 2,231 | $0.00 | $0 | 2,231 |
| 2022-05-01 | Kearney Terrence C | Dir |
Equity grant / award
A
|
Common Stock | 725 | $0.00 | $0 | 6,536 |
| 2022-04-29 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 10 | $278.04 | $2,780 | 14,334 |
| 2022-04-29 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 22 | $276.72 | $6,088 | 14,344 |
| 2022-04-29 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 30 | $275.62 | $8,269 | 14,366 |
| 2022-04-29 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 41 | $274.75 | $11,265 | 14,396 |
| 2022-04-29 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 17 | $273.37 | $4,647 | 14,437 |
| 2022-04-25 | Ambrose Kristen | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 104 | $271.68 | $28,255 | 3,496 |
| 2022-04-25 | Ambrose Kristen | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 83 | $269.51 | $22,369 | 3,600 |
| 2022-04-25 | Ambrose Kristen | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 80 | $268.46 | $21,477 | 3,683 |
| 2022-04-25 | Ambrose Kristen | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 60 | $267.37 | $16,042 | 3,763 |
| 2022-04-18 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 0 |
| 2022-04-18 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 119 | $286.80 | $34,129 | 1,875 |
| 2022-04-18 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 491 | $285.16 | $140,014 | 1,994 |
| 2022-04-18 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,008 | $284.06 | $286,332 | 2,485 |
| 2022-04-18 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 382 | $282.70 | $107,991 | 3,493 |
| 2022-04-18 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-14 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 2,000 |
| 2022-04-14 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 400 | $291.18 | $116,472 | 1,875 |
| 2022-04-14 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 252 | $288.92 | $72,808 | 2,675 |
| 2022-04-14 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 948 | $287.87 | $272,901 | 2,927 |
| 2022-04-14 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-13 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 4,000 |
| 2022-04-13 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 354 | $291.12 | $103,056 | 1,875 |
| 2022-04-13 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 400 | $288.55 | $115,420 | 2,429 |
| 2022-04-13 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 200 | $290.17 | $58,034 | 2,229 |
| 2022-04-13 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 228 | $284.90 | $64,957 | 3,329 |
| 2022-04-13 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 300 | $286.24 | $85,872 | 3,029 |
| 2022-04-13 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 18 | $281.49 | $5,067 | 3,857 |
| 2022-04-13 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-13 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 15,789 | $289.04 | $4,563,653 | 74,160 |
| 2022-04-12 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 6,000 |
| 2022-04-12 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 300 | $283.15 | $84,945 | 1,875 |
| 2022-04-12 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 318 | $281.70 | $89,581 | 2,175 |
| 2022-04-12 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,182 | $280.61 | $331,681 | 2,493 |
| 2022-04-12 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 200 | $279.22 | $55,844 | 3,675 |
| 2022-04-12 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-11 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 8,000 |
| 2022-04-11 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 110 | $281.58 | $30,974 | 1,875 |
| 2022-04-11 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 968 | $280.62 | $271,640 | 1,985 |
| 2022-04-11 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 922 | $279.81 | $257,985 | 2,953 |
| 2022-04-11 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-08 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 10,000 |
| 2022-04-08 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 452 | $280.37 | $126,727 | 1,875 |
| 2022-04-08 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 700 | $279.36 | $195,552 | 2,327 |
| 2022-04-08 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 430 | $277.29 | $119,235 | 3,027 |
| 2022-04-08 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 418 | $276.62 | $115,627 | 3,457 |
| 2022-04-08 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-07 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 12,000 |
| 2022-04-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 100 | $277.02 | $27,702 | 1,875 |
| 2022-04-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 727 | $276.37 | $200,921 | 1,975 |
| 2022-04-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 256 | $275.26 | $70,467 | 2,702 |
| 2022-04-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 500 | $273.78 | $136,890 | 2,958 |
| 2022-04-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 417 | $272.76 | $113,741 | 3,458 |
| 2022-04-07 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-07 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 30 | $277.02 | $8,311 | 42,782 |
| 2022-04-07 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 327 | $276.39 | $90,380 | 42,812 |
| 2022-04-07 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 204 | $275.71 | $56,245 | 43,139 |
| 2022-04-06 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 14,000 |
| 2022-04-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 83 | $272.84 | $22,646 | 1,875 |
| 2022-04-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,600 | $271.78 | $434,848 | 1,958 |
| 2022-04-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 300 | $270.67 | $81,201 | 3,558 |
| 2022-04-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 17 | $267.57 | $4,549 | 3,858 |
| 2022-04-06 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $81.54 | $163,080 | 3,875 |
| 2022-04-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 3,163 | $275.23 | $870,552 | 43,343 |
| 2022-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 257 | $268.43 | $68,987 | 46,506 |
| 2022-04-04 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 305 | $267.10 | $81,466 | 46,763 |
| 2022-04-01 | Ambrose Kristen | SVP & Chief Accounting Officer |
Other disposed transaction
F
|
Common Stock | 137 | $263.09 | $36,043 | 3,823 |
| 2022-03-31 | MCGLYNN MARGARET G | Dir |
Exercise / conversion
M · derivative
|
Common Stock (right to buy) | 5,000 | $127.54 | $637,700 | 10,000 |
| 2022-03-31 | MCGLYNN MARGARET G | Dir |
Open-market sell
S
|
Common Stock | 1,011 | $262.97 | $265,863 | 1,099 |
| 2022-03-31 | MCGLYNN MARGARET G | Dir |
Open-market sell
S
|
Common Stock | 2,970 | $262.37 | $779,239 | 2,110 |
| 2022-03-31 | MCGLYNN MARGARET G | Dir |
Open-market sell
S
|
Common Stock | 1,019 | $261.28 | $266,244 | 5,080 |
| 2022-03-31 | MCGLYNN MARGARET G | Dir |
Exercise / conversion
M
|
Common Stock | 5,000 | $127.54 | $637,700 | 6,099 |
| 2022-03-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 34 | $251.24 | $8,542 | 47,356 |
| 2022-03-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Open-market sell
S
|
Common Stock | 2,799 | $250.10 | $700,030 | 47,390 |
| 2022-02-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,189 | $227.86 | $498,786 | 49,373 |
| 2022-02-17 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 3,439 | $232.51 | $799,602 | 51,562 |
| 2022-02-14 | ALTSHULER DAVID | EVP, Global Research and CSO |
Open-market sell
S
|
Common Stock | 2,444 | $232.02 | $567,057 | 57,438 |
| 2022-02-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,434 | $237.74 | $578,659 | 55,001 |
| 2022-02-02 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 2,944 | $250.07 | $736,206 | 57,435 |
| 2022-02-01 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 10,262 | $0.00 | $0 | 60,379 |
| 2022-02-01 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 11,628 | $0.00 | $0 | 50,117 |
| 2022-02-01 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 3,698 | $0.00 | $0 | 38,489 |
| 2022-01-28 | MCGLYNN MARGARET G | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 5,000 | $127.54 | $637,700 | 15,000 |
| 2022-01-28 | MCGLYNN MARGARET G | Dir |
Open-market sell
S
|
Common Stock | 212 | $243.24 | $51,567 | 1,099 |
| 2022-01-28 | MCGLYNN MARGARET G | Dir |
Open-market sell
S
|
Common Stock | 2,087 | $242.78 | $506,682 | 1,311 |
| 2022-01-28 | MCGLYNN MARGARET G | Dir |
Open-market sell
S
|
Common Stock | 800 | $241.83 | $193,464 | 3,398 |
| 2022-01-28 | MCGLYNN MARGARET G | Dir |
Open-market sell
S
|
Common Stock | 1,901 | $240.53 | $457,248 | 4,198 |
| 2022-01-28 | MCGLYNN MARGARET G | Dir |
Exercise / conversion
M
|
Common Stock | 5,000 | $127.54 | $637,700 | 6,099 |
| 2022-01-14 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 190 | $230.58 | $43,750 | 13,672 |
| 2021-11-15 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 30 | $187.48 | $5,624 | 31,928 |
| 2021-11-15 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 21 | $186.78 | $3,922 | 31,958 |
| 2021-11-01 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Other disposed transaction
F
|
Common Stock | 766 | $185.07 | $141,764 | 32,576 |
| 2021-10-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 240 | $182.07 | $43,750 | 13,483 |
| 2021-08-19 | Kewalramani Reshma | CEO & President |
Open-market buy
P
|
Common Stock | 4,243 | $196.34 | $833,071 | 73,754 |
| 2021-08-19 | Kewalramani Reshma | CEO & President |
Open-market buy
P
|
Common Stock | 5,757 | $195.14 | $1,123,421 | 69,511 |
| 2021-08-02 | SACHS BRUCE I | Dir |
Open-market buy
P
|
Common Stock | 15,000 | $197.91 | $2,968,650 | 41,210 |
| 2021-07-30 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Other disposed transaction
F
|
Common Stock | 766 | $200.39 | $153,499 | 33,342 |
| 2021-07-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 221 | $198.00 | $43,750 | 13,242 |
| 2021-06-02 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 121 | $211.00 | $25,531 | 5,191 |
| 2021-06-02 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 153 | $210.01 | $32,132 | 5,312 |
| 2021-06-02 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 285 | $208.96 | $59,554 | 5,465 |
| 2021-06-01 | MCGLYNN MARGARET G | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 699 | — | — | 4,688 |
| 2021-06-01 | MCGLYNN MARGARET G | Dir |
Other disposed transaction
D
|
Common Stock | 699 | — | — | 1,099 |
| 2021-05-28 | Bozic Carmen | EVP and CMO |
Other disposed transaction
F
|
Common Stock | 311 | $210.04 | $65,322 | 32,953 |
| 2021-05-17 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 47 | $216.88 | $10,193 | 34,108 |
| 2021-05-17 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 65 | $215.95 | $14,037 | 34,155 |
| 2021-05-01 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 6,067 | $0.00 | $0 | 6,067 |
| 2021-04-30 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 547 | $217.21 | $118,814 | 34,679 |
| 2021-04-27 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,884 | $0.00 | $0 | 0 |
| 2021-04-27 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 200 | $217.69 | $43,538 | 40,133 |
| 2021-04-27 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 1,338 | $216.67 | $289,904 | 40,333 |
| 2021-04-27 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 2,346 | $215.58 | $505,751 | 41,671 |
| 2021-04-27 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M
|
Common Stock | 3,884 | $86.52 | $336,044 | 44,017 |
| 2021-04-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 199 | $220.17 | $43,750 | 13,021 |
| 2021-04-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 389 | $214.99 | $83,631 | 35,834 |
| 2021-04-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Open-market sell
S
|
Common Stock | 1,297 | $213.89 | $277,415 | 36,223 |
| 2021-04-01 | Sanna Bastiano | EVP, Cell & Genetic Therapies |
Other disposed transaction
F
|
Common Stock | 1,344 | $214.16 | $287,831 | 37,520 |
| 2021-03-05 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 256 | $212.28 | $54,344 | 8,253 |
| 2021-03-05 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 1,460 | $211.67 | $309,038 | 8,509 |
| 2021-03-05 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 844 | $210.64 | $177,780 | 9,969 |
| 2021-03-05 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 111 | $209.37 | $23,240 | 10,813 |
| 2021-03-05 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 1,119 | $208.39 | $233,188 | 10,924 |
| 2021-03-05 | Liu Joy | SVP, General Counsel |
Open-market sell
S
|
Common Stock | 1,351 | $207.57 | $280,427 | 12,043 |
| 2021-03-01 | Silva Paul M | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 231 | $213.12 | $49,231 | 9,884 |
| 2021-03-01 | Silva Paul M | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 915 | $212.51 | $194,447 | 10,115 |
| 2021-03-01 | Silva Paul M | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 610 | $211.45 | $128,984 | 11,030 |
| 2021-03-01 | Silva Paul M | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 1,026 | $210.13 | $215,593 | 11,640 |
| 2021-02-26 | Silva Paul M | SVP & Chief Accounting Officer |
Other disposed transaction
F
|
Common Stock | 2,218 | $212.42 | $471,148 | 12,666 |
| 2021-02-24 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 547 | $217.57 | $119,011 | 35,226 |
| 2021-02-17 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. |
Other disposed transaction
F
|
Common Stock | 2,000 | $211.75 | $423,500 | 32,468 |
| 2021-02-11 | Silva Paul M | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 210 | $211.32 | $44,377 | 23,863 |
| 2021-02-11 | Silva Paul M | SVP & Chief Accounting Officer |
Open-market sell
S
|
Common Stock | 1,288 | $210.45 | $271,060 | 24,073 |
| 2021-02-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 2,365 | $214.16 | $506,488 | 35,773 |
| 2021-02-05 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 1,930 | $215.00 | $414,950 | 57,227 |
| 2021-02-05 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Exercise / conversion
M · derivative
|
Common Stock | 1,930 | $0.00 | $0 | 0 |
| 2021-02-03 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 11,627 | $0.00 | $0 | 38,138 |
| 2021-02-03 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 10,324 | $0.00 | $0 | 26,511 |
| 2021-01-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 194 | $225.99 | $43,750 | 12,823 |
| 2020-11-16 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 8 | $224.44 | $1,796 | 35,103 |
| 2020-11-16 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 22 | $223.76 | $4,923 | 35,111 |
| 2020-11-16 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 12 | $222.50 | $2,670 | 35,133 |
| 2020-11-10 | SACHS BRUCE I | Dir |
Open-market buy
P
|
Common Stock | 3,905 | $218.79 | $854,375 | 26,210 |
| 2020-11-10 | SACHS BRUCE I | Dir |
Open-market buy
P
|
Common Stock | 4,270 | $217.49 | $928,682 | 22,305 |
| 2020-11-10 | SACHS BRUCE I | Dir |
Open-market buy
P
|
Common Stock | 6,825 | $216.47 | $1,477,408 | 18,035 |
| 2020-11-04 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,330 | $0.00 | $0 | 2,330 |
| 2020-11-04 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 200 | $221.25 | $44,250 | 26,838 |
| 2020-11-04 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 300 | $220.10 | $66,030 | 27,038 |
| 2020-11-04 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 600 | $218.63 | $131,178 | 27,338 |
| 2020-11-04 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 630 | $215.16 | $135,551 | 28,538 |
| 2020-11-04 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Exercise / conversion
M
|
Common Stock | 2,330 | $86.52 | $201,592 | 29,168 |
| 2020-11-03 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,553 | $0.00 | $0 | 1,554 |
| 2020-11-03 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Open-market sell
S
|
Common Stock | 334 | $214.13 | $71,519 | 35,179 |
| 2020-11-03 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Open-market sell
S
|
Common Stock | 245 | $212.38 | $52,033 | 35,513 |
| 2020-11-03 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Open-market sell
S
|
Common Stock | 487 | $211.54 | $103,020 | 35,758 |
| 2020-11-03 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Exercise / conversion
M
|
Common Stock | 1,553 | $86.52 | $134,366 | 36,732 |
| 2020-10-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 196 | $222.81 | $43,750 | 12,629 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 8,729 | $0.00 | $0 | 0 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 2,212 | $268.61 | $594,165 | 3,908 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 2,670 | $267.92 | $715,346 | 6,120 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 2,070 | $266.66 | $551,986 | 8,790 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 1,787 | $265.82 | $475,020 | 10,860 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 892 | $264.60 | $236,023 | 12,647 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 594 | $263.54 | $156,543 | 13,539 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Open-market sell
S
|
Common Stock | 291 | $262.66 | $76,434 | 14,133 |
| 2020-10-05 | Bhatia Sangeeta N. | Dir |
Exercise / conversion
M
|
Common Stock | 8,729 | $126.68 | $1,105,790 | 14,424 |
| 2020-08-25 | MCGLYNN MARGARET G | Dir |
Equity grant / award
G
|
Common Stock | 3,707 | $0.00 | $0 | 877 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 612 | $0.00 | $0 | 3,669 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 466 | $0.00 | $0 | 4,656 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 74 | $272.87 | $20,192 | 14,932 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 373 | $272.15 | $101,512 | 15,006 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 211 | $270.92 | $57,164 | 15,379 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 420 | $270.12 | $113,450 | 15,590 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Exercise / conversion
M
|
Common Stock | 612 | $155.57 | $95,209 | 16,010 |
| 2020-08-06 | Silva Paul M | SVP & Controller |
Exercise / conversion
M
|
Common Stock | 466 | $187.53 | $87,389 | 15,398 |
| 2020-08-03 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,941 | $0.00 | $0 | 3,884 |
| 2020-08-03 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 751 | $279.18 | $209,664 | 35,103 |
| 2020-08-03 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 690 | $278.25 | $191,992 | 35,854 |
| 2020-08-03 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 500 | $276.96 | $138,480 | 36,544 |
| 2020-08-03 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M
|
Common Stock | 1,941 | $86.52 | $167,935 | 37,044 |
| 2020-07-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 155 | $292.77 | $45,453 | 12,433 |
| 2020-07-13 | Silva Paul M | SVP & Controller |
Exercise / conversion
M · derivative
|
Stock Options (Right to Buy) | 860 | $0.00 | $0 | 0 |
| 2020-07-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 250 | $294.99 | $73,748 | 15,032 |
| 2020-07-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 200 | $294.18 | $58,836 | 15,282 |
| 2020-07-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 50 | $291.97 | $14,598 | 15,482 |
| 2020-07-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 60 | $285.71 | $17,143 | 15,632 |
| 2020-07-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 100 | $295.78 | $29,578 | 14,932 |
| 2020-07-13 | Silva Paul M | SVP & Controller |
Exercise / conversion
M
|
Common Stock | 860 | $90.29 | $77,649 | 15,792 |
| 2020-07-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 260 | $293.90 | $76,414 | 16,126 |
| 2020-07-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 400 | $292.86 | $117,144 | 16,386 |
| 2020-07-10 | WAGNER CHARLES F JR | EVP & Chief Financial Officer |
Open-market sell
S
|
Common Stock | 40 | $291.19 | $11,648 | 16,786 |
| 2020-07-07 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to buy) | 1,222 | $0.00 | $0 | 8,561 |
| 2020-07-07 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to buy) | 1,564 | $0.00 | $0 | 17,206 |
| 2020-07-07 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Open-market sell
S
|
Common Stock | 2,786 | $300.00 | $835,800 | 35,179 |
| 2020-07-07 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Exercise / conversion
M
|
Common Stock | 1,222 | $155.57 | $190,107 | 37,965 |
| 2020-07-07 | Arbuckle Stuart A | EVP, Chief Commercial Officer |
Exercise / conversion
M
|
Common Stock | 1,564 | $187.53 | $293,297 | 36,743 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 200 | $291.34 | $58,268 | 2,261 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 2,534 | $290.51 | $736,152 | 2,461 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 500 | $289.39 | $144,695 | 4,995 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 1,318 | $287.91 | $379,465 | 5,495 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 4,885 | $287.23 | $1,403,119 | 6,813 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 8,321 | $286.13 | $2,380,888 | 11,698 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 9,233 | $285.11 | $2,632,421 | 20,019 |
| 2020-06-30 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 5,801 | $284.14 | $1,648,296 | 29,252 |
| 2020-06-03 | MCKENZIE DIANA | Dir |
Equity grant / award
A
|
Common Stock | 1,435 | $0.00 | $0 | 1,435 |
| 2020-06-01 | YOUNG WILLIAM D | Dir |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 4,527 | $0.00 | $0 | 4,527 |
| 2020-05-29 | Bozic Carmen | EVP and CMO |
Other disposed transaction
F
|
Common Stock | 311 | $282.74 | $87,932 | 13,991 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 19 | $287.63 | $5,465 | 26,635 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 27 | $286.07 | $7,724 | 26,654 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 10 | $283.76 | $2,838 | 26,681 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 4 | $282.74 | $1,131 | 26,691 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 9 | $288.37 | $2,595 | 26,626 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 7 | $279.70 | $1,958 | 26,710 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 6 | $281.74 | $1,690 | 26,695 |
| 2020-05-15 | Kewalramani Reshma | CEO & President |
Open-market sell
S
|
Common Stock | 2 | $274.37 | $549 | 26,723 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 24,348 | $0.00 | $0 | 0 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,470 | $0.00 | $0 | 93,866 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 35,499 | $0.00 | $0 | 0 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 24,215 | $0.00 | $0 | 0 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 100 | $288.42 | $28,842 | 34,983 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 9,630 | $287.81 | $2,771,610 | 35,083 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 15,792 | $286.70 | $4,527,566 | 44,713 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 8,391 | $285.68 | $2,397,141 | 60,505 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 10,179 | $285.06 | $2,901,626 | 68,896 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 9,219 | $283.86 | $2,616,905 | 79,075 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 9,780 | $282.66 | $2,764,415 | 88,294 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 9,398 | $281.83 | $2,648,638 | 98,074 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 6,498 | $280.76 | $1,824,378 | 107,472 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 1,940 | $278.96 | $541,182 | 113,970 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 4,428 | $277.94 | $1,230,718 | 115,910 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 9,015 | $277.14 | $2,498,417 | 120,338 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 24,348 | $155.57 | $3,787,818 | 129,353 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 4,470 | $91.05 | $406,994 | 105,005 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 35,499 | $96.87 | $3,438,788 | 100,535 |
| 2020-05-12 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 24,215 | $187.53 | $4,541,039 | 65,036 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 10,665 | $0.00 | $0 | 0 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 100 | $286.72 | $28,672 | 35,103 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 1,367 | $285.94 | $390,880 | 35,203 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 2,314 | $285.15 | $659,837 | 36,570 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 1,100 | $283.98 | $312,378 | 38,884 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 913 | $282.89 | $258,279 | 39,984 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 1,398 | $281.74 | $393,873 | 40,897 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 1,817 | $280.77 | $510,159 | 42,295 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 655 | $279.67 | $183,184 | 44,112 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 201 | $277.38 | $55,753 | 44,767 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 800 | $276.25 | $221,000 | 44,968 |
| 2020-05-11 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M
|
Common Stock | 10,665 | $131.89 | $1,406,607 | 45,768 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 22,500 | $0.00 | $0 | 0 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 2,960 | $272.46 | $806,482 | 11,210 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 6,232 | $271.63 | $1,692,798 | 14,170 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 5,889 | $270.49 | $1,592,916 | 20,402 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 15,751 | $269.53 | $4,245,367 | 26,291 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 11,568 | $268.65 | $3,107,743 | 42,042 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Open-market sell
S
|
Common Stock | 2,600 | $267.50 | $695,500 | 53,610 |
| 2020-05-07 | SACHS BRUCE I | Dir |
Exercise / conversion
M
|
Common Stock | 22,500 | $81.54 | $1,834,650 | 56,210 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 407 | $0.00 | $0 | 2,854 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 559 | $0.00 | $0 | 6,145 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Open-market sell
S
|
Common Stock | 30 | $275.30 | $8,259 | 12,738 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Open-market sell
S
|
Common Stock | 330 | $274.13 | $90,463 | 12,768 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Open-market sell
S
|
Common Stock | 210 | $273.15 | $57,362 | 13,098 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Open-market sell
S
|
Common Stock | 217 | $272.09 | $59,044 | 13,308 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Open-market sell
S
|
Common Stock | 136 | $270.19 | $36,746 | 13,525 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Open-market sell
S
|
Common Stock | 43 | $268.80 | $11,558 | 13,661 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Exercise / conversion
M
|
Common Stock | 407 | $155.57 | $63,317 | 13,704 |
| 2020-05-06 | Tatsis Ourania | EVP, Chief Regulatory Officer |
Exercise / conversion
M
|
Common Stock | 559 | $187.53 | $104,829 | 13,297 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 13,356 | $0.00 | $0 | 11,334 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 200 | $273.59 | $54,718 | 35,103 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 403 | $272.58 | $109,850 | 35,303 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 11,553 | $270.01 | $3,119,426 | 35,806 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 700 | $269.08 | $188,356 | 47,359 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 300 | $267.34 | $80,202 | 48,059 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 100 | $271.09 | $27,109 | 35,706 |
| 2020-05-05 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M
|
Common Stock | 13,356 | $131.89 | $1,761,523 | 48,459 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 24,349 | $0.00 | $0 | 48,697 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,470 | $0.00 | $0 | 102,806 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 35,502 | $0.00 | $0 | 70,998 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 24,216 | $0.00 | $0 | 48,431 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 5,375 | $273.70 | $1,471,138 | 46,656 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 12,849 | $272.97 | $3,507,392 | 52,031 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 11,832 | $272.12 | $3,219,724 | 64,880 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 6,003 | $270.86 | $1,625,973 | 76,712 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 15,681 | $269.56 | $4,226,970 | 82,715 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 22,613 | $268.86 | $6,079,731 | 98,396 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 10,878 | $267.62 | $2,911,170 | 121,009 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 4,921 | $266.66 | $1,312,234 | 131,887 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Open-market sell
S
|
Common Stock | 4,220 | $265.57 | $1,120,705 | 136,808 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 24,349 | $155.57 | $3,787,974 | 141,028 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 4,470 | $91.05 | $406,994 | 116,679 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 35,502 | $96.87 | $3,439,079 | 112,209 |
| 2020-05-05 | LEIDEN JEFFREY M | Executive Chairman |
Exercise / conversion
M
|
Common Stock | 24,216 | $187.53 | $4,541,226 | 76,707 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,942 | $0.00 | $0 | 5,825 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 9,310 | $0.00 | $0 | 24,690 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 32,500 | $0.00 | $0 | 0 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 12,940 | $264.92 | $3,428,065 | 35,103 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 964 | $263.58 | $254,091 | 48,043 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 9,447 | $262.69 | $2,481,632 | 49,007 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 4,395 | $261.68 | $1,150,084 | 58,454 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 8,383 | $260.48 | $2,183,604 | 62,849 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 6,223 | $259.63 | $1,615,677 | 71,232 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Open-market sell
S
|
Common Stock | 1,400 | $258.59 | $362,026 | 77,455 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M
|
Common Stock | 1,942 | $86.52 | $168,022 | 78,855 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M
|
Common Stock | 9,310 | $131.89 | $1,227,896 | 76,913 |
| 2020-05-04 | Sachdev Amit | EVP, Chief Patient Officer |
Exercise / conversion
M
|
Common Stock | 32,500 | $109.14 | $3,547,050 | 67,603 |
| 2020-04-30 | WAGNER CHARLES F JR | EVP and CFO |
Other disposed transaction
F
|
Common Stock | 547 | $251.78 | $137,724 | 16,727 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,125 | $0.00 | $0 | 2,125 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 100 | $258.15 | $25,815 | 26,838 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 500 | $256.63 | $128,315 | 26,938 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 680 | $255.44 | $173,699 | 27,438 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 400 | $254.20 | $101,680 | 28,118 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 300 | $252.70 | $75,810 | 28,518 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Open-market sell
S
|
Common Stock | 145 | $251.38 | $36,450 | 28,818 |
| 2020-04-29 | Parini Michael | EVP, Chief Adm, Leg & BD Off |
Exercise / conversion
M
|
Common Stock | 2,125 | $90.29 | $191,866 | 28,963 |
| 2020-04-28 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,125 | $0.00 | $0 | 0 |
| 2020-04-28 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 116 | $261.80 | $30,369 | 1,875 |
| 2020-04-28 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 180 | $260.53 | $46,895 | 1,991 |
| 2020-04-28 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 120 | $259.61 | $31,153 | 2,171 |
| 2020-04-28 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 149 | $257.20 | $38,323 | 2,411 |
| 2020-04-28 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 240 | $255.79 | $61,390 | 2,560 |
| 2020-04-28 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 200 | $254.81 | $50,962 | 2,800 |
| 2020-04-28 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 1,125 | $57.27 | $64,429 | 3,000 |
| 2020-04-27 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 1,125 |
| 2020-04-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 100 | $273.44 | $27,344 | 1,875 |
| 2020-04-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 200 | $272.51 | $54,502 | 1,975 |
| 2020-04-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,113 | $271.56 | $302,246 | 2,175 |
| 2020-04-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 394 | $270.37 | $106,526 | 3,288 |
| 2020-04-27 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 193 | $268.40 | $51,801 | 3,682 |
| 2020-04-27 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-04-24 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 3,125 |
| 2020-04-24 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 120 | $270.30 | $32,436 | 1,875 |
| 2020-04-24 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 400 | $269.28 | $107,712 | 1,995 |
| 2020-04-24 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 590 | $268.31 | $158,303 | 2,395 |
| 2020-04-24 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 890 | $267.23 | $237,835 | 2,985 |
| 2020-04-24 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-04-23 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 5,125 |
| 2020-04-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 47 | $276.45 | $12,993 | 1,875 |
| 2020-04-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 600 | $275.90 | $165,540 | 1,922 |
| 2020-04-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 400 | $274.23 | $109,692 | 2,522 |
| 2020-04-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 100 | $272.55 | $27,255 | 2,922 |
| 2020-04-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 300 | $271.03 | $81,309 | 3,022 |
| 2020-04-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 200 | $269.23 | $53,846 | 3,322 |
| 2020-04-23 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 353 | $267.47 | $94,417 | 3,522 |
| 2020-04-23 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-04-22 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 7,125 |
| 2020-04-22 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 369 | $270.54 | $99,829 | 1,875 |
| 2020-04-22 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 224 | $268.48 | $60,140 | 2,544 |
| 2020-04-22 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 507 | $267.34 | $135,541 | 2,768 |
| 2020-04-22 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 300 | $269.47 | $80,841 | 2,244 |
| 2020-04-22 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-04-21 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 9,125 |
| 2020-04-21 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 100 | $272.63 | $27,263 | 1,875 |
| 2020-04-21 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 403 | $267.15 | $107,661 | 2,375 |
| 2020-04-21 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 300 | $271.38 | $81,414 | 1,975 |
| 2020-04-21 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 500 | $264.80 | $132,400 | 3,078 |
| 2020-04-21 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 297 | $263.20 | $78,170 | 3,578 |
| 2020-04-21 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-04-20 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 11,125 |
| 2020-04-20 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 500 | $274.65 | $137,325 | 1,875 |
| 2020-04-20 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 890 | $273.61 | $243,513 | 2,375 |
| 2020-04-20 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 510 | $271.52 | $138,475 | 3,265 |
| 2020-04-20 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 100 | $269.97 | $26,997 | 3,775 |
| 2020-04-20 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-04-15 | SACHS BRUCE I | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 179 | $258.56 | $46,250 | 12,277 |
| 2020-04-13 | Silva Paul M | SVP & Controller |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 859 | $0.00 | $0 | 860 |
| 2020-04-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 166 | $252.26 | $41,875 | 14,932 |
| 2020-04-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 193 | $250.29 | $48,306 | 15,098 |
| 2020-04-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 150 | $248.96 | $37,344 | 15,291 |
| 2020-04-13 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 50 | $244.09 | $12,204 | 15,741 |
| 2020-04-13 | Silva Paul M | SVP & Controller |
Exercise / conversion
M
|
Common Stock | 859 | $90.29 | $77,559 | 15,791 |
| 2020-04-06 | Silva Paul M | SVP & Controller |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,891 | $0.00 | $0 | 4,892 |
| 2020-04-06 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 4,891 | $255.57 | $1,249,993 | 14,932 |
| 2020-04-06 | Silva Paul M | SVP & Controller |
Exercise / conversion
M
|
Common Stock | 4,891 | $155.57 | $760,893 | 19,823 |
| 2020-03-31 | LEIDEN JEFFREY M | Executive Chairman |
Other disposed transaction
F
|
Common Stock | 40,090 | $234.01 | $9,381,461 | 52,491 |
| 2020-02-24 | WAGNER CHARLES F JR | EVP and CFO |
Other disposed transaction
F
|
Common Stock | 542 | $239.23 | $129,663 | 17,274 |
| 2020-02-18 | Tatsis Ourania | SVP, CRO |
Open-market sell
S
|
Common Stock | 145 | $245.75 | $35,634 | 15,070 |
| 2020-02-18 | Tatsis Ourania | SVP, CRO |
Open-market sell
S
|
Common Stock | 286 | $244.99 | $70,067 | 15,215 |
| 2020-02-18 | Tatsis Ourania | SVP, CRO |
Open-market sell
S
|
Common Stock | 528 | $242.78 | $128,188 | 15,661 |
| 2020-02-18 | Tatsis Ourania | SVP, CRO |
Open-market sell
S
|
Common Stock | 160 | $243.78 | $39,005 | 15,501 |
| 2020-02-17 | Tatsis Ourania | SVP, CRO |
Other disposed transaction
F
|
Common Stock | 597 | $241.50 | $144,176 | 16,349 |
| 2020-02-11 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 1,102 | $247.93 | $273,219 | 19,688 |
| 2020-02-11 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 1,120 | $246.84 | $276,461 | 20,790 |
| 2020-02-11 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 1,700 | $245.89 | $418,013 | 21,910 |
| 2020-02-11 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 1,560 | $244.90 | $382,044 | 23,610 |
| 2020-02-11 | Silva Paul M | SVP & Controller |
Open-market sell
S
|
Common Stock | 380 | $243.59 | $92,564 | 25,170 |
| 2020-02-10 | Silva Paul M | SVP & Controller |
Other disposed transaction
F
|
Common Stock | 4,673 | $240.95 | $1,125,959 | 25,550 |
| 2020-02-07 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 14,306 |
| 2020-02-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 600 | $239.96 | $143,976 | 1,875 |
| 2020-02-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 700 | $237.51 | $166,257 | 2,675 |
| 2020-02-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 200 | $238.50 | $47,700 | 2,475 |
| 2020-02-07 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 300 | $234.84 | $70,452 | 3,575 |
| 2020-02-07 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-02-06 | Lee Yuchun | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,000 | $0.00 | $0 | 16,306 |
| 2020-02-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 100 | $244.08 | $24,408 | 1,875 |
| 2020-02-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 429 | $240.65 | $103,239 | 1,975 |
| 2020-02-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 400 | $239.28 | $95,712 | 2,404 |
| 2020-02-06 | Lee Yuchun | Dir |
Open-market sell
S
|
Common Stock | 1,071 | $238.71 | $255,658 | 2,804 |
| 2020-02-06 | Lee Yuchun | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $57.27 | $114,540 | 3,875 |
| 2020-02-05 | WAGNER CHARLES F JR | EVP and CFO |
Equity grant / award
A
|
Common Stock | 10,323 | $0.00 | $0 | 17,816 |
| 2020-02-05 | WAGNER CHARLES F JR | EVP and CFO |
Equity grant / award
A
|
Common Stock | 3,698 | $0.00 | $0 | 7,493 |
| 2020-02-05 | LEIDEN JEFFREY M | CEO & President |
Equity grant / award
A
|
Common Stock | 31,462 | $0.00 | $0 | 216,818 |
| 2020-02-05 | LEIDEN JEFFREY M | CEO & President |
Equity grant / award
A
|
Common Stock | 28,444 | $0.00 | $0 | 185,356 |
| 2020-02-05 | LEIDEN JEFFREY M | CEO & President |
Equity grant / award
A
|
Common Stock | 50,566 | $0.00 | $0 | 156,912 |